Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 2191
interventional 1667
Observational 485
Registry 39

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 506
Drug 389
Other 215
Device 167
Behavioral 151
Procedure 58
Device|Drug 18
Device|Other 16
Device|Drug|placebo 12
Biological|placebo 11
Diagnostic Test 11
Dietary Supplement|placebo 11
Dietary Supplement 10
Behavioral|Other 9
Biological 9
Other|placebo 9
Drug|Other 7
Behavioral|Drug 5
Behavioral|Device 4
Device|Procedure 3
Dietary Supplement|Drug 3
Drug|Other|placebo 3
Other|Procedure 3
Radiation 3
Behavioral|Dietary Supplement|placebo 2
Biological|Drug 2
Combination Product 2
Device|Drug|Other 2
Device|Radiation 2
Diagnostic Test|Other 2
Dietary Supplement|Other 2
Drug|placebo|Procedure 2
Drug|Radiation 2
Behavioral|Biological|Diagnostic Test 1
Behavioral|Device|Procedure 1
Behavioral|Drug|placebo 1
Combination Product|Drug|placebo 1
Combination Product|placebo 1
Device|Other|Procedure|Radiation 1
Device|placebo 1
Diagnostic Test|Procedure 1
Dietary Supplement|Other|placebo 1
Drug|Genetic|Procedure 1
Drug|Other|placebo|Procedure 1
Drug|Other|Procedure 1
Drug|placebo|Radiation 1
Drug|Procedure 1
Genetic 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 348
United Kingdom 140
NA 106
Germany 92
Canada 73
France 61
China 53
Netherlands 39
Italy 37
Brazil 35
Spain 35
Belgium 31
Denmark 31
Japan 30
Norway 20
Sweden 14
Turkey 14
United States|Canada 14
Switzerland 13
Taiwan 12
Kyrgyzstan 11
Israel 9
Korea, Republic of 9
Tunisia 9
Australia 8
Poland 8
Ireland 7
Portugal 7
Australia|New Zealand 6
Greece 6
Hong Kong 6
Austria 5
Netherlands|United Kingdom 5
United States|Germany 5
Belgium|Netherlands 4
Egypt 4
India 4
New Zealand 4
United States|Australia|New Zealand 4
Hungary 3
Indonesia 3
Russian Federation 3
Singapore 3
Sweden|United Kingdom 3
Thailand 3
Argentina 2
Denmark|Norway|Sweden 2
Germany|Spain|United Kingdom 2
Germany|Switzerland 2
Germany|United Kingdom 2
Japan| 2
Slovenia 2
United States|Australia|Canada|New Zealand 2
United States|Puerto Rico 2
United States|United Kingdom 2
Andorra|Austria|Belgium|Bulgaria|Czech Republic|Denmark|France|Germany|Hungary|Italy|Netherlands|Poland|Romania|Russian Federation|Spain|United Kingdom 1
Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Colombia|Costa Rica|Czech Republic|Denmark|Estonia|Finland|France|Germany|Hungary|Iceland|India|Israel|Italy|Latvia|Lithuania|Mexico|Netherlands|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Venezuela 1
Argentina|Australia|Belgium|Brazil|Denmark|Germany|India|Philippines|United Kingdom 1
Argentina|Australia|Canada|Chile|Czechia|France|Greece|Hungary|Korea, Republic of|Netherlands|Russian Federation|South Africa|United Kingdom 1
Argentina|Australia|France|Germany|Italy|Japan|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Spain 1
Argentina|Australia|Germany|India|United Kingdom| 1
Argentina|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Greece|Hungary|Latvia|Lithuania|Netherlands|Poland|Romania|Serbia|Slovakia|Spain|United Kingdom 1
Argentina|Brazil|Bulgaria|Chile|Germany|Korea, Republic of|Slovakia|Spain 1
Argentina|Brazil|Canada|Croatia|Czech Republic|Denmark|Finland|Germany|Hong Kong|India|Italy|Korea, Republic of|Malaysia|Norway|Philippines|South Africa|Spain|Sweden|Thailand|Ukraine 1
Argentina|Brazil|Canada|Czech Republic|Denmark|Finland|Germany|Hong Kong|India|Italy|Korea, Republic of|Malaysia|Norway|Philippines|Romania|Russian Federation|South Africa|Spain|Sweden|Thailand 1
Argentina|Brazil|Chile|Dominican Republic|Ecuador|Honduras|Mexico|Panama 1
Argentina|Chile|China|Taiwan 1
Argentina|Chile|Colombia|Czech Republic|Denmark|Ecuador|Egypt|Estonia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Netherlands|Peru|Romania|Russian Federation|Slovakia|Spain|Switzerland|Turkey|United Kingdom 1
Argentina|Chile|Czechia|Germany|Hungary|Norway|Romania|Russian Federation|Spain|Sweden 1
Argentina|Chile|Estonia|France|Germany|Hungary|Italy|Peru|Poland|Romania|Russian Federation|Slovakia 1
Argentina|Chile|New Zealand|South Africa 1
Argentina|Colombia|Croatia|Estonia|Hungary|India|Israel|Korea, Republic of|Latvia|Mexico|Panama|Poland|Russian Federation|Serbia|Slovenia|Turkey|United Kingdom 1
Argentina|Colombia|Italy|Malaysia|Mexico|Netherlands|Spain|Switzerland|United Kingdom 1
Argentina|France|Germany|Italy|Norway|Russian Federation|Ukraine 1
Argentina|Mexico|Russian Federation|Ukraine 1
Australia|Austria|Belgium|Brazil|Canada|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Poland|Russian Federation|Slovakia|South Africa|Spain|Turkey|United Kingdom 1
Australia|Austria|Canada|France|Germany 1
Australia|Austria|Canada|France|Hungary|Italy|Netherlands|Poland|Portugal|Russian Federation|South Africa|Spain|Switzerland|United Kingdom 1
Australia|Austria|Germany|Ireland 1
Australia|Belgium|Brazil|Bulgaria|China|Denmark|France|Germany|Greece|Hungary|Italy|Netherlands|New Zealand|Philippines|Poland|Russian Federation|South Africa|Spain|Taiwan|Tunisia|Turkey|Ukraine|United Kingdom 1
Australia|Belgium|Bulgaria|Denmark|Finland|Germany|Greece|Hong Kong|Hungary|Israel|Malaysia|Poland|Romania|Singapore|South Africa|Spain|Sweden|Thailand 1
Australia|Belgium|Canada|France|Germany|Italy|Spain|Turkey 1
Australia|Bulgaria|Germany|Netherlands|New Zealand|Romania 1
Australia|China|India 1
Australia|China|Korea, Republic of|New Zealand|Taiwan 1
Australia|Czech Republic|Poland|Russian Federation 1
Australia|Denmark|Norway 1
Australia|Germany|Netherlands|New Zealand|Poland|South Africa|Spain 1
Austria|Belgium|Bulgaria|Croatia|Czech Republic|Denmark|Finland|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Ukraine|United Kingdom 1
Austria|Belgium|Bulgaria|Czech Republic|Denmark|Finland|France|Germany|Hungary|Israel|Italy|Latvia|Lithuania|Netherlands|Norway|Poland|Portugal|Romania|Russian Federation|Slovakia|Slovenia|Spain|Turkey|Ukraine|United Kingdom 1
Austria|Belgium|Canada|France|Germany|Italy|Netherlands|South Africa|Spain|United Kingdom 1
Austria|Belgium|Canada|Germany|Russian Federation 1
Austria|Belgium|Czech Republic|Denmark|Estonia|Germany|Greece|Italy|Latvia|Lithuania|Netherlands|Norway|Romania|Russian Federation|Slovakia|Slovenia|Spain|Sweden|Ukraine|United Kingdom| 1
Austria|Belgium|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Ireland|Italy|Latvia|Lithuania|Norway|Poland|Portugal|Romania|Russian Federation|Slovakia|Slovenia|Spain|Sweden|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Netherlands|South Africa|Sweden 1
Austria|Belgium|France|Germany|Netherlands|United Kingdom 1
Austria|Belgium|Germany|Italy|Spain|United Kingdom 1
Austria|Bulgaria|Canada|Czech Republic|France|Germany|Hungary|Italy|Lithuania|Netherlands|Poland|South Africa|Spain|United Kingdom 1
Austria|Canada|France|Germany|Italy|Russian Federation|Sweden 1
Austria|Denmark|Finland|France|Slovenia 1
Austria|Denmark|Netherlands|Norway|Sweden 1
Austria|France 1
Austria|France|Germany|Hungary|Italy|Spain|United Kingdom 1
Austria|France|Germany|Israel 1
Bangladesh 1
Belgium|Bulgaria|Greece|Hungary|Ireland|Russian Federation|Slovakia|Spain|Turkey|United Kingdom 1
Belgium|Canada|Chile|Germany 1
Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|South Africa 1
Belgium|Canada|Germany|Netherlands 1
Belgium|Canada|Germany|Spain|United Kingdom 1
Belgium|Czech Republic|Denmark|Germany|Hungary|Netherlands|Spain|Sweden 1
Belgium|Czech Republic|Estonia|Germany|Hungary|Korea, Republic of|Lithuania|Norway|Spain 1
Belgium|Denmark|Finland|Germany|Netherlands 1
Belgium|Denmark|Germany|Hungary 1
Belgium|Denmark|Germany|Netherlands 1
Belgium|Denmark|Netherlands|Romania|Russian Federation 1
Belgium|France 1
Belgium|France|Germany|Italy|Philippines|Poland|Russian Federation|Spain|Ukraine 1
Belgium|France|Japan 1
Belgium|Germany 1
Belgium|Hungary 1
Belgium|Italy|Netherlands 1
Belgium|Sweden 1
Belgium|United Kingdom 1
Bulgaria 1
Bulgaria|China|Czechia|Estonia|Germany|Greece|Hungary|Italy|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Slovakia|Ukraine 1
Bulgaria|Cyprus|Greece 1
Bulgaria|Czech Republic|Hungary|Poland|Romania|Slovakia 1
Bulgaria|Denmark|Poland|Slovakia|Sweden 1
Bulgaria|Finland|Germany|Hungary|Slovakia 1
Bulgaria|France|Hungary|Italy|Poland|Russian Federation|Slovakia|Ukraine 1
Bulgaria|Germany|Hungary|Korea, Republic of|Latvia|Lithuania|Macedonia, The Former Yugoslav Republic of|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
Bulgaria|Germany|Hungary|Poland|Russian Federation|United Kingdom 1
Bulgaria|Germany|Hungary|Ukraine 1
Bulgaria|Germany|Poland|United Kingdom 1
Bulgaria|Japan|Romania|Russian Federation|Ukraine 1
Bulgaria|Romania|Russian Federation 1
Bulgaria|Slovakia 1
Canada|Colombia|Czech Republic|Denmark|Finland|France|Germany|Hungary|Iceland|India|Italy|Peru|Russian Federation|Slovakia|Taiwan 1
Canada|Croatia|Czech Republic|Estonia|France|Germany|Guatemala|India|Korea, Republic of|Latvia|Lithuania|Philippines|Poland|South Africa|Taiwan 1
Canada|Denmark 1
Canada|Denmark|Netherlands|Romania|Ukraine 1
Canada|France|Hungary|India|Korea, Republic of|Latvia|Lithuania|Romania|South Africa|United Kingdom 1
Canada|France|Portugal|Spain 1
Canada|Germany|Hungary|Spain 1
Canada|Germany|Netherlands|Sweden 1
Canada|Germany|Spain 1
Canada|United States|Australia|Germany|Japan|Korea, Republic of|Philippines|Poland|Russian Federation|Slovakia|Taiwan|Ukraine 1
Chile 1
China|Hong Kong|Indonesia|Korea, Republic of|Thailand 1
China|India|Korea, Republic of|Philippines 1
China|Japan|Korea, Republic of 1
China|Korea, Republic of 1
China|Korea, Republic of|Philippines|Taiwan 1
China|Korea, Republic of|Philippines|Taiwan|Thailand 1
China|Korea, Republic of|Taiwan 1
Colombia 1
Colombia|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|Finland|France|Germany|Hong Kong|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Thailand|Turkey|Ukraine|United Kingdom|Vietnam 1
Croatia 1
Cyprus 1
Czech Republic|France|Germany|Hungary|Italy|Peru|Poland|Russian Federation|South Africa|Spain|Ukraine 1
Czech Republic|Germany|Hungary|Poland 1
Czech Republic|Romania 1
Czechia 1
Czechia|Germany|Greece|Netherlands 1
Czechia|Germany|Hungary|Romania 1
Czechia|Hungary 1
Denmark|Czechia|Germany|Hungary|Netherlands|Poland|Russian Federation|Spain 1
Denmark|Estonia|Finland|Italy|Lithuania|Slovakia|Spain|United Kingdom 1
Denmark|Finland|Germany|Netherlands|United Kingdom 1
Denmark|Finland|Germany|Norway|Sweden 1
Denmark|Finland|Netherlands|Norway 1
Denmark|Finland|Netherlands|Norway|Sweden 1
Denmark|Germany 1
Denmark|Germany|Poland|Sweden|United Kingdom 1
Estonia|Finland 1
Estonia|Finland|Germany|Korea, Republic of|Latvia|Lithuania|Netherlands|New Zealand|Russian Federation|Slovenia|South Africa|United Kingdom 1
Estonia|Finland|Germany|Netherlands|Russian Federation|Slovakia 1
Estonia|Slovenia|Spain|Sweden|United Kingdom 1
Finland|United Kingdom 1
France|Germany|Italy|Spain 1
France|United States|Colombia|Egypt|Guatemala|Hungary|Panama|Slovakia|Slovenia 1
Germany|Argentina|Austria|Belgium|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Estonia|Finland|France|Greece|Guatemala|Hong Kong|Hungary|Iceland|India|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
Germany|Czech Republic|Hungary|Korea, Republic of|Malaysia|Poland|Russian Federation|Taiwan 1
Germany|Denmark|Sweden|United Kingdom 1
Germany|Estonia 1
Germany|Greece|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Croatia|Czech Republic|Denmark|Estonia|Finland|France|Hong Kong|Hungary|Iceland|Italy|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Pakistan|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Ukraine|United Kingdom| 1
Germany|Hungary|Italy 1
Germany|Hungary|Italy|Spain|United Kingdom 1
Germany|Italy|South Africa|Switzerland 1
Germany|Netherlands 1
Germany|Netherlands|Russian Federation|Sweden|United Kingdom 1
Germany|Netherlands|Spain|Sweden|United Kingdom 1
Germany|Netherlands|United Kingdom 1
Germany|New Zealand|Russian Federation|Sweden|United Kingdom 1
Germany|Poland 1
Germany|South Africa 1
Germany|Spain 1
Germany|United States|Belgium|Canada|Denmark|Hungary|Netherlands 1
Germany|United States|Belgium|Hungary 1
Hong Kong|India|Japan|Korea, Republic of|Singapore|Taiwan 1
Hong Kong|Korea, Republic of|Malaysia|Philippines|Taiwan 1
Hong Kong|Korea, Republic of|Philippines|Taiwan 1
Hungary|Belgium|Bulgaria|Finland|Germany|Israel|Poland|Romania|Russian Federation|Sweden 1
Hungary|Slovakia 1
Iceland 1
India|Japan|Korea, Republic of|Philippines|Poland|Russian Federation|Taiwan|Ukraine|Vietnam 1
Iran, Islamic Republic of 1
Italy|Spain|Sweden 1
Italy|Switzerland 1
Japan|United States|Argentina|Czechia|Germany|Poland|Romania|Russian Federation|Ukraine 1
Korea, Republic of|United States|Australia|Canada|Japan|Netherlands|Romania|Russian Federation|Singapore|Spain|Turkey 1
Latvia|United States|Bulgaria|Czech Republic|Hungary|Lithuania|Philippines|Poland|Ukraine|United Kingdom 1
Malaysia 1
Morocco|Tunisia 1
Netherlands|South Africa 1
Netherlands|United States|Argentina|Australia|Canada|Chile|Estonia|Germany|Italy|Mexico|Peru|Philippines|South Africa|Sweden|United Kingdom 1
Netherlands|United States|Belgium|Canada|Czechia|Germany|Hungary|Poland|Romania|Russian Federation|United Kingdom 1
New Zealand|Thailand|United Kingdom 1
Norway|Sweden 1
Pakistan 1
Peru 1
Poland|United Kingdom 1
Russian Federation|Finland|Germany|Netherlands|United Kingdom 1
Saudi Arabia 1
Slovakia 1
Slovakia|Ukraine 1
South Africa 1
South Africa|Estonia|Germany|Netherlands|Romania|Russian Federation|Slovakia|Sweden|Ukraine 1
South Africa|United Kingdom 1
Spain|Australia|Canada|France|Germany|Hungary|Poland|Slovakia|Sweden 1
Spain|France|Germany 1
Spain|Sweden 1
Spain|United States|Canada|Denmark|Germany|Poland|United Kingdom 1
United Kingdom|Belgium|Greece|Netherlands|Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|Finland|France|Germany|Greece|Guatemala|Hong Kong|Hungary|India|Ireland|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom|Vietnam 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Czech Republic|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|Netherlands|Ireland|Italy|Japan|Lithuania|Malaysia|Mexico|New Zealand|Norway|Philippines|Poland|Portugal|Russian Federation|Singapore|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|Chile|Germany|Italy|New Zealand 1
United States|Argentina|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Greece|Guatemala|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Philippines|Poland|Slovakia|Spain|Thailand|Turkey 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Colombia|Czechia|Denmark|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Philippines|Poland|Spain|Sweden|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Chile|Colombia|Croatia|Denmark|France|Israel|Mexico|New Zealand|Norway|Peru|Philippines|Poland|Serbia|Slovenia|Sweden|Taiwan|Thailand|Turkey|Ukraine|Vietnam 1
United States|Argentina|Australia|Bulgaria|Canada|Chile|Czech Republic|Hungary|India|New Zealand|Poland|Slovakia|South Africa|Sweden|United Kingdom 1
United States|Argentina|Australia|Bulgaria|Canada|China|Czech Republic|Denmark|Estonia|Finland|France|Germany|Guatemala|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Portugal|Russian Federation|Slovenia|Turkey 1
United States|Argentina|Australia|Canada|Chile|Denmark|Germany|Italy|Mexico|Netherlands|Peru|South Africa|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Canada|Chile|Denmark|Germany|Japan|Korea, Republic of|Netherlands|Romania|Slovakia|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Canada|Chile|Germany|Korea, Republic of|Mexico|Romania|South Africa 1
United States|Argentina|Australia|Canada|Chile|Germany|Poland|Russian Federation|Turkey|Ukraine 1
United States|Argentina|Australia|Canada|France|Germany|Sweden|Italy|Mexico|Netherlands|South Africa|Spain 1
United States|Argentina|Australia|Canada|Mexico|New Zealand|South Africa 1
United States|Argentina|Australia|Colombia|Denmark|Germany|Guatemala|Mexico|Philippines|South Africa|Spain|Turkey 1
United States|Argentina|Austria|Canada|Colombia|Czech Republic|Hungary|Denmark|Estonia|Finland|France|Germany|Greece|India|Ireland|Israel|Italy|Mexico|Netherlands|Peru|Philippines|Poland|Puerto Rico|Russian Federation|Slovakia|South Africa|Spain|United Kingdom 1
United States|Argentina|Austria|Canada|Germany|Netherlands|Russian Federation|Sweden 1
United States|Argentina|Brazil|Canada|Germany|Italy|Portugal|Russian Federation|Spain|Taiwan|Ukraine 1
United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru|South Africa|Venezuela 1
United States|Argentina|Brazil|Chile|Costa Rica|Mexico 1
United States|Argentina|Bulgaria|Canada|Chile|China|Czechia|Denmark|Finland|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Slovakia|Spain|Sweden|Turkey|Ukraine 1
United States|Argentina|Bulgaria|Canada|Chile|Colombia|Croatia|Hong Kong|Hungary|India|Mexico|Philippines|Puerto Rico|Singapore|Taiwan|Thailand 1
United States|Argentina|Bulgaria|Canada|Chile|Germany|Hungary|Korea, Republic of|Netherlands|Philippines|Romania|South Africa|Thailand|United Kingdom 1
United States|Argentina|Bulgaria|Canada|Czech Republic|Germany|Hungary|Japan|Poland|Slovakia|South Africa|Spain|Sweden|Taiwan 1
United States|Argentina|Bulgaria|Canada|Denmark|Hungary|Mexico|Poland|Russian Federation 1
United States|Argentina|Bulgaria|Canada|Germany|Hungary|Romania|Russian Federation|Spain 1
United States|Argentina|Bulgaria|Croatia|Czechia|Germany|Hungary|Poland|Slovakia|South Africa|Spain|Turkey 1
United States|Argentina|Canada|Australia|Austria|Belgium|Brazil|Bulgaria|China|Colombia|Croatia|Denmark|Finland|France|Georgia|Germany|Greece|Guatemala|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Panama|Peru|Philippines|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Tunisia|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Canada|Chile|Colombia|Italy|Malaysia|Mexico|Peru|Philippines|Romania|Russian Federation|Serbia|Spain|Taiwan|Thailand|Ukraine 1
United States|Argentina|Canada|Chile|Denmark|Estonia|Germany|Korea, Republic of|Mexico|Peru|Philippines|Poland|Russian Federation|Slovakia 1
United States|Argentina|Canada|Chile|Denmark|France|Germany|Italy|Korea, Republic of|Romania|Russian Federation|South Africa|Ukraine 1
United States|Argentina|Canada|Chile|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Russian Federation 1
United States|Argentina|Canada|Chile|Romania 1
United States|Argentina|Canada|Colombia|Mexico|Peru 1
United States|Argentina|Canada|Finland|France|Germany|Hungary|Italy|Spain|United Kingdom 1
United States|Argentina|Canada|Germany|India|Italy|Korea, Republic of|Puerto Rico|Spain|Sweden|Taiwan|Turkey 1
United States|Argentina|Canada|Germany|India|Italy|Spain|Sweden|Turkey 1
United States|Argentina|Chile|Greece|Peru|Romania|Ukraine 1
United States|Argentina|Chile|Guatemala|Honduras|Romania 1
United States|Argentina|Chile|Netherlands|Peru|South Africa 1
United States|Argentina|Czechia|Estonia|Germany|Korea, Republic of|Norway|Ukraine 1
United States|Argentina|Estonia|Germany|Korea, Republic of|Norway|Russian Federation|South Africa|Sweden|Ukraine 1
United States|Argentina|France|Greece|Korea, Republic of|New Zealand|Poland|Russian Federation|South Africa|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Germany|Poland|Romania|Russian Federation|Ukraine 1
United States|Argentina|Germany|Russian Federation|Ukraine 1
United States|Argentina|Lithuania|Slovakia|United Kingdom 1
United States|Argentina|Norway 1
United States|Australia|Austria|Belgium|Canada|Denmark|Germany|New Zealand|Poland|Portugal|United Kingdom 1
United States|Australia|Austria|Brazil|France|Germany|Hungary|New Zealand|Romania|Russian Federation|United Kingdom 1
United States|Australia|Austria|Canada|Finland|France|Greece|Ireland|Italy|Netherlands|New Zealand|Russian Federation|South Africa|Spain|United Kingdom 1
United States|Australia|Austria|Canada|Germany|Greece|New Zealand|Norway|Slovakia|South Africa|Sweden 1
United States|Australia|Belgium|Canada|Czechia|Estonia|France|Greece|Italy|Mexico|Norway|Peru|Poland|Russian Federation|Spain|Sweden 1
United States|Australia|Belgium|Canada|France|Germany|Greece|Netherlands|Norway|Russian Federation|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Germany|Hungary|Israel|Netherlands|New Zealand|Poland|Spain|United Kingdom 1
United States|Australia|Brazil|Canada|China|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Ireland|Italy|Korea, Republic of|Lithuania|Malaysia|Mexico|Netherlands|Norway|Portugal|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Bulgaria|Canada|France|Germany|Guatemala|Hungary|Japan|Philippines|Poland|Russian Federation|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada|Germany 1
United States|Australia|Canada|Germany|Korea, Republic of|Netherlands|Poland|Romania|Spain 1
United States|Australia|China|Germany|New Zealand|Taiwan 1
United States|Australia|Denmark|Finland|Hungary|New Zealand|Poland|Sweden 1
United States|Austria|Belgium|Brazil|Canada|China|Colombia|Croatia|Germany|Hungary|India|Ireland|Japan|Norway|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Austria|Belgium|Canada|Colombia|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Mexico|Norway|Poland|Russian Federation|Slovakia|Spain|Switzerland|Turkey|United Kingdom 1
United States|Austria|Canada|Czechia|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|South Africa|Spain|Switzerland|United Kingdom 1
United States|Austria|Netherlands|United Kingdom 1
United States|Belgium|Canada|Czech Republic|Denmark|Finland|Germany|South Africa|Spain|United Kingdom 1
United States|Belgium|Canada|Czech Republic|Germany|Greece|Netherlands|Portugal|Ukraine|United Kingdom 1
United States|Belgium|Canada|Denmark|Italy|Spain 1
United States|Belgium|Canada|Germany 1
United States|Belgium|Canada|Germany|Netherlands 1
United States|Belgium|Denmark|Estonia|France|Germany|Hungary|Japan|Netherlands|Norway|Philippines|Slovakia|Sweden|Ukraine 1
United States|Belgium|Germany|Hungary|Netherlands|Poland|Spain 1
United States|Belgium|Netherlands 1
United States|Belgium|New Zealand 1
United States|Belgium|Spain 1
United States|Bulgaria|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Canada|Chile|China|Colombia|Croatia|Czechia|France|Georgia|Germany|Greece|Hungary|India|Indonesia|Israel|Italy|Japan|Korea, Republic of|Latvia|Macedonia, The Former Yugoslav Republic of|Malaysia|Mexico|Netherlands|Philippines|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom|Vietnam 1
United States|Bulgaria|Canada|Chile|Czechia|Greece|Japan|Mexico|Poland|Russian Federation|South Africa|Spain|Thailand 1
United States|Bulgaria|Canada|France|Hungary|Russian Federation|Ukraine 1
United States|Bulgaria|Czechia|Germany|Hungary|Israel|Poland|Spain|Ukraine|United Kingdom 1
United States|Bulgaria|Czechia|Germany|Hungary|Italy|Latvia|Poland|Romania|Russian Federation 1
United States|Bulgaria|Denmark|Germany|Greece|Hungary|Iceland|Mexico|Romania 1
United States|Bulgaria|Estonia|Germany|Russian Federation|United Kingdom 1
United States|Bulgaria|Finland|Hungary|Puerto Rico|Romania|Spain 1
United States|Bulgaria|Germany|Hungary|Romania|Russian Federation|Ukraine 1
United States|Bulgaria|Germany|Japan|Korea, Republic of|Poland|Romania|Russian Federation|South Africa|Taiwan|Ukraine 1
United States|Canada|Colombia|Czech Republic|Hungary|India|Netherlands|Slovakia|Spain 1
United States|Canada|Czechia|Denmark|South Africa|Ukraine|United Kingdom 1
United States|Canada|Czechia|Germany|Poland|Romania 1
United States|Canada|Denmark|France|Germany|Israel|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Canada|Denmark|France|Germany|Netherlands|Romania|United Kingdom 1
United States|Canada|France|Germany|Poland|South Africa 1
United States|Canada|France|Poland|South Africa|Spain|United Kingdom 1
United States|Canada|Germany 1
United States|Canada|Germany|Hungary|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Taiwan 1
United States|Canada|Germany|India|Italy|Poland|South Africa|Spain 1
United States|Canada|Germany|Korea, Republic of 1
United States|Canada|Germany|Netherlands 1
United States|Canada|Germany|Netherlands|Spain 1
United States|Canada|Philippines|Poland|Romania|Spain|Ukraine|Vietnam 1
United States|Chile|Czech Republic|Korea, Republic of|Poland 1
United States|Chile|Estonia|Germany|Japan|Korea, Republic of|Mexico|Philippines|Poland|Russian Federation 1
United States|Chile|Estonia|Russian Federation 1
United States|Chile|Mexico|Norway|Romania|Russian Federation|South Africa 1
United States|Chile|Romania|Russian Federation|Slovakia|South Africa 1
United States|China|Czechia|Germany|Hungary|Japan|Korea, Republic of|Poland|Russian Federation|Taiwan|United Kingdom 1
United States|China|Germany|Taiwan 1
United States|Czech Republic|Germany|Hungary|India|Slovakia|Spain|Turkey 1
United States|Czech Republic|Germany|Korea, Republic of 1
United States|Czech Republic|Germany|Poland|Romania|South Africa 1
United States|Czech Republic|Netherlands|Poland|South Africa 1
United States|Czechia|Germany 1
United States|Czechia|Germany|Netherlands 1
United States|Czechia|Germany|Poland|Romania|Russian Federation 1
United States|Czechia|Hungary|Russian Federation 1
United States|Estonia|Germany|Poland 1
United States|Finland|Greece|Italy|Portugal|Sweden|Turkey|United Kingdom 1
United States|France|Germany|Italy|Mexico|Peru|Poland|Romania|Russian Federation|Ukraine 1
United States|France|Germany|Netherlands|Spain|Turkey 1
United States|France|Italy|Spain 1
United States|Germany|Italy|Romania|United Kingdom 1
United States|Germany|Italy|South Africa|Spain|Ukraine 1
United States|Germany|Japan 1
United States|Germany|Korea, Republic of|Norway|Philippines|Thailand 1
United States|Germany|Netherlands|Norway 1
United States|Germany|Romania|Russian Federation|Ukraine 1
United States|Germany|South Africa 1
United States|Germany|Spain|United Kingdom 1
United States|Netherlands|United Kingdom 1
United States|Poland 1
United States|Poland|Russian Federation 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 924
2 136
3 43
4 42
5 30
6 26
7 15
8 18
9 9
10 15
11 12
12 13
13 10
14 9
15 8
16 6
17 8
18 8
19 10
20 11
21 7
22 3
23 3
24 5
25 7
26 6
27 9
28 4
29 6
30 4
31 6
32 5
33 4
34 5
35 4
36 1
37 5
38 1
39 4
40 6
41 2
42 4
43 5
44 4
45 5
46 1
47 1
48 3
49 4
50 4
51 4
52 3
53 5
54 6
55 5
56 2
57 3
58 1
59 2
60 5
61 2
62 3
64 3
65 1
66 2
67 1
68 3
69 1
70 1
71 1
72 3
73 3
74 1
75 1
76 1
77 1
78 2
79 1
80 1
81 1
83 2
85 1
86 1
88 1
90 2
91 1
92 1
93 2
94 3
95 1
96 2
97 3
98 1
99 1
100 2
101 1
103 2
104 1
105 1
106 1
107 1
110 1
112 3
113 1
114 1
115 1
116 3
118 1
120 3
125 1
126 1
127 1
130 1
132 3
134 1
137 2
138 1
139 1
140 2
143 3
144 1
149 1
157 2
160 1
163 1
165 1
166 2
167 2
170 1
176 1
177 1
178 2
179 1
180 2
183 2
188 1
191 1
197 1
208 1
212 1
213 1
215 1
216 1
222 2
238 1
239 1
240 1
247 1
248 1
270 1
287 1
334 1
338 1
345 2
356 1
409 1
424 1
459 1
468 1
490 1
496 1
544 1
752 1
818 1
999 1
1191 1
1621 1

Phase

Phase Study_Count
N/A 618
Phase 3 331
Phase 2 259
Phase 4 238
Phase 1 165
Phase 1/Phase 2 27
Phase 2/Phase 3 18
Early Phase 1 11

Number of Arms

Number_of_Arms Count_of_Studies
1 199
2 888
3 192
4 112
5 55
6 40
7 8
8 18
9 4
10 2
11 2
12 4
14 1
16 1
NA 141

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 5.00000 3.0000 4.00000 15.0000 6.0000 10.0000 14.0000 4.0000
1st Qu. 19.50000 27.0000 16.00000 25.0000 40.0000 29.2500 159.5000 40.0000
Median 34.00000 60.0000 28.00000 34.0000 76.0000 115.5000 458.5000 124.0000
Mean 91.90909 561.7435 40.45732 234.5185 165.2031 272.7222 844.3364 347.8017
3rd Qu. 94.00000 150.0000 45.00000 62.5000 193.2500 180.0000 933.2500 318.0000
Max. 341.00000 197692.0000 420.00000 5000.0000 2080.0000 2059.0000 17183.0000 7376.0000

Trial Group Type

group_type Group_Count
Experimental 2155
Active Comparator 771
Placebo Comparator 522
No Intervention 208
Other 175
NA 141
Sham Comparator 39

Intervention Model

intervention_model Study_Count
Parallel Assignment 1009
Crossover Assignment 411
Single Group Assignment 215
NA 13
Factorial Assignment 10
Sequential Assignment 9

Primary Purpose

primary_purpose Study_Count
Treatment 1175
Supportive Care 115
Basic Science 83
Prevention 69
Other 60
Health Services Research 59
Diagnostic 47
NA 46
Screening 9
Device Feasibility 3
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
NA 90
United States 72
United Kingdom 49
Germany 31
France 28
China 23
Canada 17
Spain 16
Italy 12
Taiwan 11
Japan 9
Norway 9
Sweden 9
Greece 8
Korea, Republic of 8
Denmark 7
Russian Federation 6
Belgium 5
Brazil 5
Turkey 5
Ireland 4
Israel 4
Netherlands 4
Switzerland 4
Austria 3
Egypt 3
Kazakhstan 2
Argentina|Colombia|Uruguay|Venezuela 1
Australia 1
Australia|China|Korea, Republic of|Taiwan 1
Australia|Germany 1
Australia|New Zealand|United Kingdom 1
Austria|Belgium|Denmark|Finland|France|Germany|Greece|Ireland|Italy|Netherlands|Norway|Portugal|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Austria|Czechia|Hungary|Israel|Romania|Russian Federation|Slovakia|Slovenia|Switzerland 1
Belgium|Denmark|Finland|Germany|Netherlands|Norway 1
Belgium|France|Germany|Greece|Ireland|Italy|Netherlands|Spain|Sweden 1
Belgium|France|Germany|Netherlands|Poland|Spain 1
Belgium|Greece|Netherlands|United Kingdom 1
Bulgaria 1
Bulgaria|Greece|Hong Kong|Korea, Republic of|Norway|Slovakia 1
Canada|France 1
Chile 1
Costa Rica 1
Croatia 1
Czechia 1
Denmark|France|Germany 1
Denmark|France|Netherlands 1
Denmark|Germany|United Kingdom 1
Hong Kong 1
Hungary|Slovakia|Slovenia 1
India 1
Israel|United Kingdom 1
Italy|Croatia|Denmark|Ireland|Netherlands|Norway|Portugal|Spain|Sweden|United Kingdom 1
Kyrgyzstan 1
Netherlands|United Kingdom 1
Poland|Croatia|Romania|Russian Federation|Slovakia|Slovenia 1
Qatar 1
Romania 1
Romania|Bulgaria|Czechia|Hungary|Israel|Lithuania|Poland|Russian Federation|Slovenia|Switzerland|Ukraine 1
Serbia 1
Thailand 1
Uganda 1
United States|Argentina|Australia|Brazil|Canada|China|Colombia|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Norway|Spain|Sweden|United Kingdom 1
United States|Belgium|Canada|Denmark|Finland|Germany|Japan|Korea, Republic of|Poland|Spain|Sweden|United Kingdom 1
United States|Bulgaria|Canada|Czech Republic|Denmark|Netherlands|New Zealand|Norway|Slovenia|Spain|Ukraine|United Kingdom 1
United States|Bulgaria|Canada|Czech Republic|France|Germany|Italy|Russian Federation|Sweden 1
United States|Germany|Italy 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 350
2 27
3 14
4 6
5 7
6 4
8 5
9 2
10 2
11 1
12 2
13 3
14 1
15 4
17 1
18 1
19 5
20 5
21 1
22 3
23 1
25 1
26 2
28 1
30 1
32 2
40 2
41 1
42 1
44 1
47 2
50 1
51 1
52 1
57 1
60 1
71 1
74 1
79 1
89 1
90 1
108 1
123 1
141 1
169 1
177 1
185 1
188 1
233 1
301 1
352 1
388 1
418 1
605 1
606 1
701 1
864 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 80.00
Median 259.00
Mean 10003.47
3rd Qu 1135.00
Max 2100000.00

Observation Model

observational_model Study_Count
Cohort 283
NA 59
Case-Only 46
Other 31
Case-Control 29
Case Control 25
Case-Crossover 7
Family-Based 3
Defined Population, Natural History 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 300
Cross-Sectional 83
Retrospective 64
NA 30
Other 5
Cross-Sectional, Prospective 1
Longitudinal, Prospective 1
Longitudinal, Retrospective 1

Registries

Studies by Country

Country Study_Count
United States 7
China 4
Korea, Republic of 4
Germany 3
United Kingdom 3
Japan 2
Spain 2
Argentina 1
Austria|Bulgaria|Croatia|Czech Republic|Hungary|Latvia|Poland|Russian Federation|Serbia|Slovakia|Slovenia 1
Austria|Spain|Switzerland|United Kingdom 1
Belgium 1
Brazil 1
France 1
Italy 1
NA 1
Netherlands 1
Russian Federation 1
Sweden 1
Taiwan 1
Tunisia 1
Turkey 1

Sites per Study

Site_count Study_Count
1 26
2 2
3 2
4 2
6 2
11 1
15 1
23 1
81 1
180 1

Enrollment Metrics

Measure Registries
Min 10.00
1st Qu 117.00
Median 505.00
Mean 88668.03
3rd Qu 3251.00
Max 2500000.00

Registry Model

observational_model Study_Count
Cohort 26
Case-Control 5
Other 5
Case-Only 2
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 23
Other 9
Cross-Sectional 7

Follow-up

target_duration Study_Count
1 Day 5
3 Years 4
12 Months 3
1 Month 2
1 Year 2
10 Years 2
2 Years 2
20 Years 2
5 Years 2
6 Months 2
8 Years 2
1 Week 1
13 Weeks 1
15 Years 1
18 Months 1
2 Days 1
2 Months 1
2 Weeks 1
24 Weeks 1
4 Years 1
7 Months 1
9 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04459143 Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives https://ClinicalTrials.gov/show/NCT04459143 Recruiting Centre Hospitalier René Dubos 2020-11-30
NCT03957577 Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan https://ClinicalTrials.gov/show/NCT03957577 Recruiting GlaxoSmithKline 2021-07-31
NCT03405363 Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists https://ClinicalTrials.gov/show/NCT03405363 Active, not recruiting Boehringer Ingelheim 2020-07-31
NCT03383601 Сohort Study to Evaluate Exacerbations, Respiratory Symptoms, Physical Exercise Intolerance and Lung Functions Among Participants Who Use IQOS With Heatsticks Compared to Smokers of Conventional Cigarettes https://ClinicalTrials.gov/show/NCT03383601 Active, not recruiting Kazakhstan Academy of Preventive Medicine 2023-06-30
NCT03381560 A Study to Evaluate the Symptoms Over 24 Hours in Patients With Chronic Obstructive Pulmonary Disease - LASSYC Study https://ClinicalTrials.gov/show/NCT03381560 Completed AstraZeneca 2018-06-30
NCT03376295 Comparative Effectiveness of COPD Treatments https://ClinicalTrials.gov/show/NCT03376295 Completed Boehringer Ingelheim 2017-12-31
NCT03823443 COPD Exacerbation Blood and Urine Biomarkers Study https://ClinicalTrials.gov/show/NCT03823443 Recruiting Columbia University 2021-08-30
NCT03359122 Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients https://ClinicalTrials.gov/show/NCT03359122 Completed AstraZeneca 2018-08-20
NCT03357341 Sensor and Electronic Health Records (EHR) Integration Pilot Study https://ClinicalTrials.gov/show/NCT03357341 Completed GlaxoSmithKline 2019-09-27
NCT03333018 A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination) https://ClinicalTrials.gov/show/NCT03333018 Completed AstraZeneca 2017-02-28
NCT03310177 Relationship Between Metabolic Profile and Clinical Phenotype in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03310177 Completed Peking University Third Hospital 2017-07-20
NCT03310164 Lung and Gut Microbiome in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03310164 Completed Peking University Third Hospital 2016-02-15
NCT03299907 COPD MSA 3 Regions: Epidemiology and Risk Factors of COPD in Rural Environment (BM3R) https://ClinicalTrials.gov/show/NCT03299907 Completed Centre Hospitalier Universitaire de Besancon 2013-05-30
NCT03299673 AdHerencE to Treatment and quAlity of Life in COPD https://ClinicalTrials.gov/show/NCT03299673 Completed Elpen Pharmaceutical Co. Inc. 2018-12-05
NCT03295474 Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System. https://ClinicalTrials.gov/show/NCT03295474 Completed ADIR Association 2018-10-30
NCT03295279 WTC Chest CT Imaging Archive https://ClinicalTrials.gov/show/NCT03295279 Active, not recruiting Icahn School of Medicine at Mount Sinai 2021-08-31
NCT03290287 Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints https://ClinicalTrials.gov/show/NCT03290287 Recruiting AstraZeneca 2023-06-30
NCT03288376 SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS https://ClinicalTrials.gov/show/NCT03288376 Completed Incyphae, Inc. 2017-01-31
NCT03287921 Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD https://ClinicalTrials.gov/show/NCT03287921 Completed Universitätsmedizin Mannheim 2018-11-30
NCT03269721 COPD-Related Physiology and the Brain https://ClinicalTrials.gov/show/NCT03269721 Recruiting University of Iowa 2020-12-31
NCT03244137 Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03244137 Completed ADIR Association 2019-12-01
NCT03240315 Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03240315 Enrolling by invitation Guangzhou Institute of Respiratory Disease 2020-08-31
NCT03238339 The Clinical Application and Popularization of Portable Home Noninvasive Ventilator https://ClinicalTrials.gov/show/NCT03238339 Recruiting Third Military Medical University 2020-12-30
NCT03227211 COPD Readmissions Prediction- ReCOPD Project https://ClinicalTrials.gov/show/NCT03227211 Recruiting Hospital Galdakao-Usansolo 2020-12-31
NCT03219255 RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term) https://ClinicalTrials.gov/show/NCT03219255 Recruiting GlaxoSmithKline 2021-03-31
NCT03212001 TeleHomecaRe InterVention Evaluation Study https://ClinicalTrials.gov/show/NCT03212001 Recruiting University of Toronto 2019-10-31
NCT03181204 Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS https://ClinicalTrials.gov/show/NCT03181204 Recruiting University Hospital, Montpellier 2020-08-07
NCT03179826 Analysis of Inhaled Corticoid Prescriptions in General Medicine https://ClinicalTrials.gov/show/NCT03179826 Completed University Hospital, Montpellier 2018-07-01
NCT03176745 Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls https://ClinicalTrials.gov/show/NCT03176745 Completed Universitätsmedizin Mannheim 2016-06-30
NCT03165045 Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®) https://ClinicalTrials.gov/show/NCT03165045 Completed Boehringer Ingelheim 2019-02-04
NCT03161587 Patient Characteristics and Treatment Modalities in COPD Patients in China https://ClinicalTrials.gov/show/NCT03161587 Completed GlaxoSmithKline 2018-12-31
NCT03146611 nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD https://ClinicalTrials.gov/show/NCT03146611 Completed Assiut University 2017-03-01
NCT03114969 Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs https://ClinicalTrials.gov/show/NCT03114969 Completed GlaxoSmithKline 2018-03-09
NCT03105999 Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD https://ClinicalTrials.gov/show/NCT03105999 Completed Laboratori Guidotti S.p.A. 2017-04-30
NCT03102970 Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. https://ClinicalTrials.gov/show/NCT03102970 Completed University Hospital, Grenoble 2018-04-05
NCT03086590 EVALUATION OF RESPIRATORY MECHANICS AND FUNCTIONALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE https://ClinicalTrials.gov/show/NCT03086590 Completed Universidade Federal de Pernambuco 2018-02-01
NCT03075709 The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan https://ClinicalTrials.gov/show/NCT03075709 Enrolling by invitation University of Saskatchewan 2020-09-30
NCT03049202 BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study https://ClinicalTrials.gov/show/NCT03049202 Recruiting Karolinska Institutet 2020-06-01
NCT03044847 The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China https://ClinicalTrials.gov/show/NCT03044847 Recruiting Beijing Chao Yang Hospital 2020-12-31
NCT03043898 Mapping Sound Propagation Through the Human Lung for Better Diagnosis https://ClinicalTrials.gov/show/NCT03043898 Recruiting University of Cambridge 2020-04-23
NCT03046069 FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey https://ClinicalTrials.gov/show/NCT03046069 Completed GlaxoSmithKline 2018-02-23
NCT03028207 A Cross-sectional Study on COPD Prevalence https://ClinicalTrials.gov/show/NCT03028207 Completed GlaxoSmithKline 2019-03-01
NCT03030638 Drug Utilization Study for Olodaterol https://ClinicalTrials.gov/show/NCT03030638 Completed Boehringer Ingelheim 2018-03-31
NCT02233894 Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02233894 Completed Boehringer Ingelheim 2002-05-31
NCT03026439 Searching Clinical Chronic Obstructive Pulmonary Disease Onset https://ClinicalTrials.gov/show/NCT03026439 Completed Pontificia Universidad Catolica de Chile 2018-06-30
NCT03018808 Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients https://ClinicalTrials.gov/show/NCT03018808 Recruiting GlaxoSmithKline 2020-07-20
NCT03020394 Respiratory Support in Severe Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT03020394 Recruiting China-Japan Friendship Hospital 2020-12-31
NCT03018470 Change in Breathing Pattern on Non-invasive Ventilation of COPD Patients Under Home Mechanical Ventilation https://ClinicalTrials.gov/show/NCT03018470 Completed University Hospital, Rouen 2017-08-31
NCT03011515 Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI) https://ClinicalTrials.gov/show/NCT03011515 Active, not recruiting MeMed Diagnostics Ltd. 2019-05-01
NCT03010592 Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD https://ClinicalTrials.gov/show/NCT03010592 Recruiting Royal Brompton & Harefield NHS Foundation Trust 2020-01-31
NCT03010566 Lung Volume Reduction Coil Microbiome Study https://ClinicalTrials.gov/show/NCT03010566 Recruiting Royal Brompton & Harefield NHS Foundation Trust 2020-01-31
NCT03004716 Telemonitoring in Pulmonary Rehabilitation: Validity of a Remote Pulse Oxymetry System https://ClinicalTrials.gov/show/NCT03004716 Completed ADIR Association 2017-03-31
NCT03003494 Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy https://ClinicalTrials.gov/show/NCT03003494 Completed Boehringer Ingelheim 2018-07-30
NCT02998944 The Study of CCTM and Common Diseases https://ClinicalTrials.gov/show/NCT02998944 Completed Shanghai Tongji Hospital, Tongji University School of Medicine 2013-12-31
NCT02993172 The Copenhagen City Heart Study https://ClinicalTrials.gov/show/NCT02993172 Completed Bispebjerg Hospital 2014-01-31
NCT02988388 Lung Tissue Research Consortium https://ClinicalTrials.gov/show/NCT02988388 Completed National Heart, Lung, and Blood Institute (NHLBI) 2019-01-28
NCT02983812 Developing Enhanced Prediction Models https://ClinicalTrials.gov/show/NCT02983812 Completed University of Pennsylvania 2019-06-07
NCT02979379 Pain in Individuals With COPD During Pulmonary Rehabilitation https://ClinicalTrials.gov/show/NCT02979379 Recruiting West Park Healthcare Centre 2018-12-31
NCT02978703 EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece https://ClinicalTrials.gov/show/NCT02978703 Completed Elpen Pharmaceutical Co. Inc. 2018-12-31
NCT02972775 15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02972775 Completed Zuyderland Medisch Centrum 2017-10-31
NCT02970422 Chronic Obstructive Pulmonary Disease Patient Preferences Survey https://ClinicalTrials.gov/show/NCT02970422 Active, not recruiting McGill University 2017-10-31
NCT02964117 Associations Between Air Pollutants Exposures and Respiratory System Study https://ClinicalTrials.gov/show/NCT02964117 Completed Peking University Third Hospital 2016-01-31
NCT02965079 Registry on the EXperience of Extracorporeal CO2 Removal in Intensive Care Units https://ClinicalTrials.gov/show/NCT02965079 Recruiting Rexecor 2020-01-31
NCT02958683 Chest Wall Motion Analysis in Disease https://ClinicalTrials.gov/show/NCT02958683 Completed Heart of England NHS Trust 2015-07-31
NCT02942797 NRS 2002 as a Predictor of Prognosis in COPD With Respiratory Failure https://ClinicalTrials.gov/show/NCT02942797 Completed West China Hospital 2019-03-22
NCT02942784 A Comparison of Three Nutritional Assessment Methods Predicting Prognosis in COPD With Respiratory Failure https://ClinicalTrials.gov/show/NCT02942784 Completed West China Hospital 2017-05-12
NCT02927795 OTIVACTO Spain Non Interventional Study https://ClinicalTrials.gov/show/NCT02927795 Completed Boehringer Ingelheim 2018-09-18
NCT02926534 Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan https://ClinicalTrials.gov/show/NCT02926534 Completed Kazakhstan Academy of Preventive Medicine 2017-05-31
NCT02923505 Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF) https://ClinicalTrials.gov/show/NCT02923505 Completed Wissenschaftliches Institut Bethanien e.V 2017-06-30
NCT02900209 Influenza Vaccination and COPD Phenotypes https://ClinicalTrials.gov/show/NCT02900209 Completed University of Lincoln 2017-09-30
NCT02898272 SCCOR Minorities Observational Study https://ClinicalTrials.gov/show/NCT02898272 Enrolling by invitation University of Pittsburgh 2019-08-31
NCT02892396 Influence of Electronic Cigarettes in the Evaluation of the Inflammatory Response in Patients With a Diagnosis of COPD https://ClinicalTrials.gov/show/NCT02892396 Completed Fundacio Catalana de Pneumologia 2018-08-31
NCT02879773 Computed Tomography Assessment of Regional Ventilation (CURVE) https://ClinicalTrials.gov/show/NCT02879773 Completed Heart of England NHS Trust 2018-06-01
NCT02873988 Regeneration of Bronchial Epithelium During Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02873988 Completed CHU de Reims 2013-12-31
NCT02873780 Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients https://ClinicalTrials.gov/show/NCT02873780 Completed Centre Hospitalier des Pays de Morlaix 2016-09-30
NCT02864407 Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02864407 Recruiting Boehringer Ingelheim 2021-08-30
NCT02865577 Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance https://ClinicalTrials.gov/show/NCT02865577 Completed University of Leicester 2017-11-29
NCT02850978 Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02850978 Completed Boehringer Ingelheim 2018-10-30
NCT02842463 6-minute Stepper Test and Pulmonary Rehabilitation in Patients With Chronicle Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02842463 Recruiting ADIR Association 2019-12-31
NCT02827721 Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02827721 Recruiting Universitätsmedizin Mannheim 2020-11-30
NCT02826954 The Nasal Airway in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02826954 Completed Norwegian University of Science and Technology 2017-11-30
NCT02826265 Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease https://ClinicalTrials.gov/show/NCT02826265 Recruiting Universitätsmedizin Mannheim 2020-12-31
NCT02814253 Chronic Obstructive Pulmonary Disease (COPD) Breathing Record Study https://ClinicalTrials.gov/show/NCT02814253 Completed Cambridge Respiratory Innovations Limited 2016-07-06
NCT02805114 Obstructive Airways Diseases in Pulmonary Clinic (OADPC) Study https://ClinicalTrials.gov/show/NCT02805114 Completed Medtronic - MITG 2018-05-21
NCT02759848 The Role of Tuberculosis in Chronic Obstructive Lung Disease https://ClinicalTrials.gov/show/NCT02759848 Completed Istanbul Medeniyet University 2014-12-31
NCT02755974 The London COPD Exacerbation Cohort https://ClinicalTrials.gov/show/NCT02755974 Recruiting Imperial College London 2021-04-30
NCT02753556 ScreenFlow: Strategy for Finding Cases of Moderate-to-Severe COPD https://ClinicalTrials.gov/show/NCT02753556 Completed Dimagi Inc. 2016-06-30
NCT02743507 The Impact of Bundled Payments on Quality and Cost of Care https://ClinicalTrials.gov/show/NCT02743507 Active, not recruiting University of Pennsylvania 2018-12-31
NCT02740686 Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD https://ClinicalTrials.gov/show/NCT02740686 Completed University of Lincoln 2018-08-28
NCT02719184 Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease) https://ClinicalTrials.gov/show/NCT02719184 Active, not recruiting Boehringer Ingelheim 2021-03-29
NCT02719639 OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS) https://ClinicalTrials.gov/show/NCT02719639 Completed Boehringer Ingelheim 2017-05-31
NCT02689492 SATisfaction and Adherence to COPD Treatment https://ClinicalTrials.gov/show/NCT02689492 Completed Boehringer Ingelheim 2017-09-15
NCT02675517 Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02675517 Completed Boehringer Ingelheim 2017-03-10
NCT02661321 Location and Timing of Inhaler Use, Exacerbations and Physical Activity in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02661321 Completed VA Puget Sound Health Care System 2014-01-31
NCT02644772 Preventing Repeat Hospitalisations in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02644772 Completed Beaumont Hospital 2017-07-31
NCT02637219 Innate Immune Response in COPD https://ClinicalTrials.gov/show/NCT02637219 Completed VA Puget Sound Health Care System 2008-01-31
NCT02626468 Validation of Structured Light Plethysmography - Health and Disease https://ClinicalTrials.gov/show/NCT02626468 Recruiting Pneumacare Ltd 2018-09-30
NCT02627872 Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02627872 Active, not recruiting Karolinska Institutet 2020-12-31
NCT02238327 Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes https://ClinicalTrials.gov/show/NCT02238327 Active, not recruiting University of Pittsburgh 2020-09-30
NCT02760329 Observational Study of Obstructive Lung Disease (NOVELTY) https://ClinicalTrials.gov/show/NCT02760329 Active, not recruiting AstraZeneca 2021-05-31
NCT03110614 Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD https://ClinicalTrials.gov/show/NCT03110614 Recruiting University of Alabama at Birmingham 2021-07-31
NCT02571582 Predictors of Mortality in Patients With Advanced Lung Disease in Home Oxygen Therapy https://ClinicalTrials.gov/show/NCT02571582 Completed Federal University of Uberlandia 2015-09-30
NCT04363723 The Influence of an Acute Exacerbation During Pulmonary Rehabilitation in COPD Patients Awaiting Lung Transplantation https://ClinicalTrials.gov/show/NCT04363723 Completed Schön Klinik Berchtesgadener Land 2020-05-10
NCT01177618 Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study https://ClinicalTrials.gov/show/NCT01177618 Recruiting Brigham and Women’s Hospital 2022-07-31
NCT02552472 A Study of Inhaler Use in the Community https://ClinicalTrials.gov/show/NCT02552472 Completed Beaumont Hospital 2015-10-31
NCT02535546 Seasonal Trends in Pneumococcal Carriage in COPD Patients https://ClinicalTrials.gov/show/NCT02535546 Completed Beaumont Hospital 2016-01-31
NCT02540408 Detection and Characterization of COPD in Dairy Farmers https://ClinicalTrials.gov/show/NCT02540408 Completed Centre Hospitalier Universitaire de Besancon 2015-11-30
NCT02534766 MISSION COPD - Modern Innovative SolutionS in Improving Outcomes iN COPD https://ClinicalTrials.gov/show/NCT02534766 Completed Portsmouth Hospitals NHS Trust 2016-08-31
NCT02522026 Follow-up-study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers https://ClinicalTrials.gov/show/NCT02522026 Completed Fraunhofer-Institute of Toxicology and Experimental Medicine 2017-03-31
NCT02498938 The Association of SERPINA1 Gene Disturbance in Patients With Lung and Gum Disorders https://ClinicalTrials.gov/show/NCT02498938 Completed Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 2015-11-30
NCT02493790 Cognitive Dysfunction in COPD Patients : Role in the Performance of Cognitive-motor Dual Task Situation? https://ClinicalTrials.gov/show/NCT02493790 Completed 5 Santé 2015-06-30
NCT02488590 Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases https://ClinicalTrials.gov/show/NCT02488590 Active, not recruiting KU Leuven 2020-04-30
NCT02490553 Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources https://ClinicalTrials.gov/show/NCT02490553 Completed University Hospital, Lille 2013-11-30
NCT02457455 Urgent Medical and Surgical Conditions During Flights https://ClinicalTrials.gov/show/NCT02457455 Completed Antalya Training and Research Hospital 2014-10-31
NCT02449083 Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patients With Shunt or Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02449083 Completed Heinrich-Heine University, Duesseldorf 2015-08-31
NCT02445079 Ugandan Non-Communicable Diseases and Aging Cohort https://ClinicalTrials.gov/show/NCT02445079 Completed Massachusetts General Hospital 2018-05-31
NCT02419872 Study in Patients’ With Persistent Asthma and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02419872 Completed Teva Pharmaceutical Industries 2017-04-07
NCT02399254 The Trajectory of Physical Activity Following Pulmonary Rehabilitation https://ClinicalTrials.gov/show/NCT02399254 Completed Saint Francis Care 2017-06-15
NCT02348060 Outcomes Data of Adipose Stem Cells to Treat Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02348060 Recruiting StemGenex 2019-05-31
NCT02346292 Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement https://ClinicalTrials.gov/show/NCT02346292 Completed AstraZeneca 2016-12-30
NCT02329522 USCOM For Assessing Patients With COPD https://ClinicalTrials.gov/show/NCT02329522 Active, not recruiting Chinese University of Hong Kong 2014-10-31
NCT02307799 A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology https://ClinicalTrials.gov/show/NCT02307799 Completed Université Catholique de Louvain 2018-01-31
NCT02284295 Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures 2 https://ClinicalTrials.gov/show/NCT02284295 Completed Novosibirsk City Hospital #2 2014-11-30
NCT02261337 Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease? https://ClinicalTrials.gov/show/NCT02261337 Active, not recruiting Royal Brompton & Harefield NHS Foundation Trust 2018-07-31
NCT02248909 Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions https://ClinicalTrials.gov/show/NCT02248909 Completed AstraZeneca 2015-05-31
NCT02244216 Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease https://ClinicalTrials.gov/show/NCT02244216 Completed Boehringer Ingelheim 2000-06-30
NCT02238197 Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02238197 Completed Boehringer Ingelheim 2001-10-31
NCT02238184 Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02238184 Completed Boehringer Ingelheim 2001-09-30
NCT02236715 Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT02236715 Completed Boehringer Ingelheim 2000-02-29
NCT02238171 Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02238171 Completed Boehringer Ingelheim 2000-12-31
NCT02238158 Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02238158 Completed Boehringer Ingelheim 2001-04-30
NCT02238145 Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT02238145 Completed Boehringer Ingelheim 1999-11-30
NCT02238132 Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT02238132 Completed Boehringer Ingelheim 1999-11-30
NCT02233920 Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis https://ClinicalTrials.gov/show/NCT02233920 Completed Boehringer Ingelheim 2000-12-31
NCT02233907 Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02233907 Completed Boehringer Ingelheim 2001-08-31
NCT02232594 Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease https://ClinicalTrials.gov/show/NCT02232594 Completed Boehringer Ingelheim 2000-12-31
NCT02233881 Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02233881 Completed Boehringer Ingelheim 2001-11-30
NCT02231437 Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease https://ClinicalTrials.gov/show/NCT02231437 Completed Boehringer Ingelheim 1999-11-30
NCT02231424 Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT02231424 Completed Boehringer Ingelheim 1999-11-30
NCT02231372 Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT02231372 Completed Boehringer Ingelheim 2004-12-31
NCT02231359 Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT02231359 Completed Boehringer Ingelheim 2004-09-30
NCT02231346 Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02231346 Completed Boehringer Ingelheim 2006-04-30
NCT02231320 Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02231320 Completed Boehringer Ingelheim 2006-06-30
NCT02220387 Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures https://ClinicalTrials.gov/show/NCT02220387 Completed Novosibirsk City Hospital #2 2014-09-30
NCT02214056 Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility https://ClinicalTrials.gov/show/NCT02214056 Completed Centre Hospitalier Universitaire de Nīmes 2015-04-30
NCT02196194 A Prescription-Event Monitoring (PEM) Study of Tiotropium https://ClinicalTrials.gov/show/NCT02196194 Completed Boehringer Ingelheim 2003-08-31
NCT02187926 Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece https://ClinicalTrials.gov/show/NCT02187926 Completed AstraZeneca 2013-12-31
NCT02176564 Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02176564 Completed Boehringer Ingelheim 2000-10-31
NCT02177318 Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02177318 Completed Boehringer Ingelheim 2007-09-30
NCT02173769 Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy https://ClinicalTrials.gov/show/NCT02173769 Completed Boehringer Ingelheim 2015-03-31
NCT02172560 A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler https://ClinicalTrials.gov/show/NCT02172560 Completed Boehringer Ingelheim 2008-01-31
NCT02172547 Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment. https://ClinicalTrials.gov/show/NCT02172547 Completed Boehringer Ingelheim 2007-01-31
NCT02172521 Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation https://ClinicalTrials.gov/show/NCT02172521 Completed Boehringer Ingelheim 2006-10-31
NCT02172495 Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice https://ClinicalTrials.gov/show/NCT02172495 Completed Boehringer Ingelheim 2003-10-31
NCT02172482 Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02172482 Completed Boehringer Ingelheim 2003-10-31
NCT02162095 Is COPD a Risk Factor for Cardiovascular Disease? https://ClinicalTrials.gov/show/NCT02162095 Completed University of Zurich 2014-12-31
NCT02143206 Modifying Exercise for the COPD Patient https://ClinicalTrials.gov/show/NCT02143206 Completed TriHealth Inc. 2014-05-31
NCT02128529 Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02128529 Completed AstraZeneca 2011-04-30
NCT02123199 Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD https://ClinicalTrials.gov/show/NCT02123199 Completed Novartis 2013-12-31
NCT02100332 A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02100332 Completed AstraZeneca 2014-07-31
NCT02096731 Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events https://ClinicalTrials.gov/show/NCT02096731 Completed Boehringer Ingelheim 2015-08-31
NCT02092675 Endothelial Dysfunction and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02092675 Completed Clinical Hospital Centre Zagreb 2014-05-31
NCT02080442 Balance Training for Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02080442 Completed West Park Healthcare Centre 2014-02-28
NCT02076061 Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study https://ClinicalTrials.gov/show/NCT02076061 Active, not recruiting Lund University 2021-05-31
NCT02068456 Post Marketing Surveillance of Roflumilast in Korea https://ClinicalTrials.gov/show/NCT02068456 Completed AstraZeneca 2017-04-26
NCT02065921 Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort https://ClinicalTrials.gov/show/NCT02065921 Recruiting Cantonal Hosptal, Baselland 2021-09-30
NCT02060292 Novel Vascular Manifestations of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT02060292 Completed North Bristol NHS Trust 2016-07-31
NCT01318174 Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01318174 Completed Sykehuset Innlandet HF 2012-04-30
NCT01308476 SMS Reminder to Assess Adherence https://ClinicalTrials.gov/show/NCT01308476 Completed Boehringer Ingelheim 2011-11-30
NCT01302587 A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) https://ClinicalTrials.gov/show/NCT01302587 Completed Teva Pharmaceutical Industries 2011-06-30
NCT01305668 Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema https://ClinicalTrials.gov/show/NCT01305668 Completed Villa Pineta Hospital 2012-12-31
NCT01297790 Cough Responses to Tussive Agents in Health and Disease https://ClinicalTrials.gov/show/NCT01297790 Completed Manchester University NHS Foundation Trust 2011-05-31
NCT01285167 Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA) https://ClinicalTrials.gov/show/NCT01285167 Completed AstraZeneca 2012-02-29
NCT02055885 Correction of Exercise-induced Desaturation by Acute Oxygen Supply and Exercise Responses in COPD https://ClinicalTrials.gov/show/NCT02055885 Completed 5 Santé 2014-02-28
NCT02050022 Chronic Obstructive Pulmonary Disease Biomarker Study https://ClinicalTrials.gov/show/NCT02050022 Active, not recruiting University of British Columbia 2017-12-31
NCT02015767 Patient Registry of Roflumilast In Real Life https://ClinicalTrials.gov/show/NCT02015767 Completed AstraZeneca 2016-08-31
NCT02006082 Readmissions to Hospital Among Patients With COPD After Telemedicine Video Consultation - a Pilot Project https://ClinicalTrials.gov/show/NCT02006082 Completed Helse Stavanger HF 2012-12-31
NCT04448626 Micro-environment Involvement in Muscle Alteration Induced https://ClinicalTrials.gov/show/NCT04448626 Completed University Hospital, Montpellier 2020-05-01
NCT01982149 Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer https://ClinicalTrials.gov/show/NCT01982149 Active, not recruiting Weill Medical College of Cornell University 2021-08-31
NCT01979081 Detecting and Addressing Preclinical Disability https://ClinicalTrials.gov/show/NCT01979081 Completed McMaster University 2017-06-30
NCT01974219 HIV-related Accelerated Aging of the Airway Epithelium https://ClinicalTrials.gov/show/NCT01974219 Recruiting Weill Medical College of Cornell University 2021-03-31
NCT01969344 Study of COPD Subgroups and Biomarkers https://ClinicalTrials.gov/show/NCT01969344 Active, not recruiting University of North Carolina, Chapel Hill 2022-05-31
NCT01949727 Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2) https://ClinicalTrials.gov/show/NCT01949727 Recruiting University of Alberta 2020-12-31
NCT01948544 Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01948544 Completed StratiHealth 2014-04-30
NCT01937390 Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01937390 Completed Boehringer Ingelheim 2016-10-22
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01923051 Czech Multicentre Research Database of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01923051 Active, not recruiting Masaryk University 2021-12-31
NCT01922180 Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation https://ClinicalTrials.gov/show/NCT01922180 Completed Erasme University Hospital 2009-08-31
NCT01880177 Developing a COPD Case Finding Methodology for Primary Care https://ClinicalTrials.gov/show/NCT01880177 Completed University of Michigan 2015-01-31
NCT01871246 Acute Exacerbation of COPD and Physical Activity - Preliminary Study https://ClinicalTrials.gov/show/NCT01871246 Active, not recruiting University of Michigan 2015-12-31
NCT01825538 Assessment of Pulmonary Specialty Physicians’ Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases https://ClinicalTrials.gov/show/NCT01825538 Completed Ohio State University 2014-06-30
NCT01819298 Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy https://ClinicalTrials.gov/show/NCT01819298 Completed Far Eastern Memorial Hospital 2012-03-31
NCT01810692 Preference Tiotropium Respimat Study in COPD https://ClinicalTrials.gov/show/NCT01810692 Completed Boehringer Ingelheim 2014-03-31
NCT01798420 Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation https://ClinicalTrials.gov/show/NCT01798420 Completed The Nazareth Hospital, Israel 2012-09-30
NCT01801722 Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01801722 Completed Lund University 2008-06-30
NCT01797367 Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START) https://ClinicalTrials.gov/show/NCT01797367 Completed University of Minnesota 2016-12-31
NCT01763463 WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects https://ClinicalTrials.gov/show/NCT01763463 Completed GlaxoSmithKline 2013-05-31
NCT01762917 Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing https://ClinicalTrials.gov/show/NCT01762917 Completed Universitätsmedizin Mannheim 2010-12-31
NCT01753427 Perception of Symptom Variability in COPD https://ClinicalTrials.gov/show/NCT01753427 Completed AstraZeneca 2013-11-30
NCT01749462 Oxis 9mcg Turbuhaler Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01749462 Completed AstraZeneca 2015-07-31
NCT01745419 Prevalence of Different Haptoglobin Phenotypes in Patients With COPD- Frequent Exacerbators Versus Non Exacerbators https://ClinicalTrials.gov/show/NCT01745419 Completed Carmel Medical Center 2015-01-31
NCT01713075 Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT01713075 Completed AstraZeneca 2015-12-31
NCT01703416 Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT01703416 Completed AstraZeneca 2013-04-30
NCT01701869 Microbiology & Immunology of the Chronically-inflamed Airway https://ClinicalTrials.gov/show/NCT01701869 Completed University Hospital Southampton NHS Foundation Trust 2015-12-31
NCT01679782 Involvement of Nervous System in Muscle Weakness in COPD Patients https://ClinicalTrials.gov/show/NCT01679782 Completed 5 Santé 2014-04-30
NCT01661374 The Effect of Humidification on Mucus Rheology https://ClinicalTrials.gov/show/NCT01661374 Completed Virginia Commonwealth University 2014-04-30
NCT01656421 Assessment of Risk in Chronic Airways Disease Evaluation https://ClinicalTrials.gov/show/NCT01656421 Completed Cardiff University 2016-12-31
NCT01655667 Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis https://ClinicalTrials.gov/show/NCT01655667 Completed Research in Real-Life Ltd 2011-02-28
NCT01646424 Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01646424 Completed AstraZeneca 2012-09-30
NCT01634620 Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease https://ClinicalTrials.gov/show/NCT01634620 Completed Aerocrine AB 2012-10-31
NCT01627743 CorRELation Between PatIent PErception and Findings on Clinical Examination https://ClinicalTrials.gov/show/NCT01627743 Completed AstraZeneca 2013-01-31
NCT01615783 Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population https://ClinicalTrials.gov/show/NCT01615783 Completed GlaxoSmithKline 2011-03-31
NCT01602237 Preventing Respiratory Health Problems in Bakery Employees https://ClinicalTrials.gov/show/NCT01602237 Completed Haukeland University Hospital 2012-12-31
NCT02024737 SILO2 (Signal Intensity Lung washOut) https://ClinicalTrials.gov/show/NCT02024737 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2015-09-30
NCT01597882 Improving Monitoring of Patients Receiving Case Management https://ClinicalTrials.gov/show/NCT01597882 Completed University of Southampton 2013-12-31
NCT01566968 Novel Endpoints in Cough Challenge Testing https://ClinicalTrials.gov/show/NCT01566968 Completed Manchester University NHS Foundation Trust 2012-04-30
NCT01564953 Magnesium is Associated With QoL in COPD: A Cross-sectional Study https://ClinicalTrials.gov/show/NCT01564953 Completed University of Aarhus 2012-10-31
NCT01554774 Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01554774 Completed Hospital Viamed Valvanera, Spain 2012-07-31
NCT01544543 Validation of HealthCare Standards in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01544543 Completed Sociedad Española de Neumología y Cirugía Torácica NA
NCT01527773 Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01527773 Completed University of Zurich 2017-01-31
NCT01515709 Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01515709 Completed Royal Brompton & Harefield NHS Foundation Trust 2013-09-30
NCT01516528 Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care https://ClinicalTrials.gov/show/NCT01516528 Completed GlaxoSmithKline 2015-05-01
NCT01507415 Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD? https://ClinicalTrials.gov/show/NCT01507415 Completed Royal Brompton & Harefield NHS Foundation Trust 2013-02-28
NCT01505543 Proprioceptive Postural Control and Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01505543 Completed KU Leuven 2012-08-31
NCT01493544 Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America https://ClinicalTrials.gov/show/NCT01493544 Completed AstraZeneca 2012-10-31
NCT01485159 Airflow Limitation in Cardiac Diseases in Europe https://ClinicalTrials.gov/show/NCT01485159 Completed GlaxoSmithKline 2012-06-30
NCT01475045 ANASA (Patients’ Satisfaction With Pulmonary Diseases’ Treatment) https://ClinicalTrials.gov/show/NCT01475045 Completed Elpen Pharmaceutical Co. Inc. 2011-04-30
NCT01470274 Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients https://ClinicalTrials.gov/show/NCT01470274 Completed Norwegian University of Science and Technology 2012-01-31
NCT01460082 Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01460082 Completed LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology 2010-09-30
NCT01455402 An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF https://ClinicalTrials.gov/show/NCT01455402 Completed MedImmune LLC 2014-05-31
NCT01431911 Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT01431911 Completed GlaxoSmithKline 2010-12-31
NCT01426893 Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct https://ClinicalTrials.gov/show/NCT01426893 Completed AstraZeneca 2012-03-31
NCT01424527 Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study https://ClinicalTrials.gov/show/NCT01424527 Completed GlaxoSmithKline 2011-04-30
NCT01423071 Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life https://ClinicalTrials.gov/show/NCT01423071 Completed Wissenschaftliches Institut Bethanien e.V 2015-01-31
NCT01419158 Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01419158 Completed Alpha-1 Foundation 2010-01-31
NCT01405222 Cough Frequency in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01405222 Completed Hull University Teaching Hospitals NHS Trust 2013-06-30
NCT01395875 Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment https://ClinicalTrials.gov/show/NCT01395875 Completed GlaxoSmithKline 2011-04-30
NCT01388218 Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01388218 Completed Barcelona Institute for Global Health 2011-12-31
NCT01387178 Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01387178 Completed GlaxoSmithKline 2010-02-28
NCT01381471 Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01381471 Completed GlaxoSmithKline 2010-05-31
NCT01381458 Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation https://ClinicalTrials.gov/show/NCT01381458 Completed GlaxoSmithKline 2010-10-31
NCT01381406 Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations https://ClinicalTrials.gov/show/NCT01381406 Completed GlaxoSmithKline 2010-06-30
NCT01380470 Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia https://ClinicalTrials.gov/show/NCT01380470 Completed Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 2010-05-31
NCT01377675 Web-based, Interactive Professional Education for Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01377675 Completed The University of Texas Health Science Center at San Antonio 2014-09-30
NCT01376830 Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients https://ClinicalTrials.gov/show/NCT01376830 Completed Imperial College London 2013-06-30
NCT01369810 Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01369810 Completed AstraZeneca 2013-09-30
NCT01366469 Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting https://ClinicalTrials.gov/show/NCT01366469 Completed Emory University 2012-12-31
NCT01360788 GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01360788 Completed Laval University NA
NCT01361451 Myotrace: An Evaluation of a Novel Critical Illness Monitoring System https://ClinicalTrials.gov/show/NCT01361451 Completed Guy’s and St Thomas’ NHS Foundation Trust 2013-10-31
NCT01337661 A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations https://ClinicalTrials.gov/show/NCT01337661 Completed MedImmune LLC 2012-01-31
NCT01337336 Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population https://ClinicalTrials.gov/show/NCT01337336 Completed GlaxoSmithKline 2010-11-30
NCT01335672 Survival After First Myocardial Infarction in Patients With and Without Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01335672 Completed London School of Hygiene and Tropical Medicine 2013-12-31
NCT01332461 Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies https://ClinicalTrials.gov/show/NCT01332461 Completed GlaxoSmithKline 2010-05-31
NCT01332409 Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone) https://ClinicalTrials.gov/show/NCT01332409 Completed GlaxoSmithKline 2012-04-30
NCT01331694 Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01331694 Completed GlaxoSmithKline 2010-05-31
NCT01325948 Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities https://ClinicalTrials.gov/show/NCT01325948 Completed AstraZeneca 2011-06-30
NCT04421742 The Effect of Beclomethasone/Formoterol in Extra-fine Formulation on Quality of Life and SAD in COPD Patients. https://ClinicalTrials.gov/show/NCT04421742 Completed University of Parma 2019-02-08
NCT04362631 Respiratory Infection Monitoring https://ClinicalTrials.gov/show/NCT04362631 Recruiting Northwestern University 2021-12-01
NCT04333901 Compliance of Long-term Home Non-invasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04333901 Recruiting Vivisol 2022-03-31
NCT04319523 Abnormal Pain Processing in COPD Patients https://ClinicalTrials.gov/show/NCT04319523 Enrolling by invitation Universidad de Granada 2020-06-15
NCT04313361 A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery https://ClinicalTrials.gov/show/NCT04313361 Recruiting Johnson & Johnson (China) Investment Ltd. 2021-03-26
NCT04315766 Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled With Primary Prevention https://ClinicalTrials.gov/show/NCT04315766 Recruiting Istituto Clinico Humanitas 2021-10-31
NCT04301245 Profile of COPD Patients Refusing Educational Program in Pulmonary Rehabilitation and Impact on the Benefits https://ClinicalTrials.gov/show/NCT04301245 Completed ADIR Association 2020-03-31
NCT04296318 COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device https://ClinicalTrials.gov/show/NCT04296318 Recruiting Mologic Ltd 2020-11-30
NCT04279730 Fatigue and Physical Performance During Pulmonary Rehabilitation https://ClinicalTrials.gov/show/NCT04279730 Recruiting 5 Santé 2020-08-31
NCT04257630 Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD https://ClinicalTrials.gov/show/NCT04257630 Recruiting Schön Klinik Berchtesgadener Land 2022-03-31
NCT04249310 Early Intervention Efficacy in COPD https://ClinicalTrials.gov/show/NCT04249310 Active, not recruiting Boehringer Ingelheim 2020-07-31
NCT04248842 Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease - Validation Study https://ClinicalTrials.gov/show/NCT04248842 Completed University Hospital Bispebjerg and Frederiksberg 2020-06-04
NCT04240353 RECEIVER: Digital Service Model for Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT04240353 Recruiting NHS Greater Glasgow and Clyde 2021-07-31
NCT04236726 Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure https://ClinicalTrials.gov/show/NCT04236726 Recruiting Guy’s and St Thomas’ NHS Foundation Trust 2021-12-31
NCT04212559 Hemodynamic Effects of Negative Pressure Ventilation in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04212559 Completed Fu Jen Catholic University 2019-11-30
NCT04202991 The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04202991 Recruiting Teesside University 2020-02-28
NCT04192175 Identification of Patients Admitted With COPD Exacerbations and Predicting Readmission Risk Using Machine Learning https://ClinicalTrials.gov/show/NCT04192175 Active, not recruiting University Health Network, Toronto 2020-05-31
NCT04183530 The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data https://ClinicalTrials.gov/show/NCT04183530 Recruiting Wuhan Union Hospital, China 2020-10-16
NCT04184297 Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy https://ClinicalTrials.gov/show/NCT04184297 Completed Boehringer Ingelheim 2019-11-04
NCT04166812 Change in Airway Peripheral Tone in COPD https://ClinicalTrials.gov/show/NCT04166812 Recruiting Heidelberg University 2022-06-30
NCT04159129 Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients https://ClinicalTrials.gov/show/NCT04159129 Recruiting Schön Klinik Berchtesgadener Land 2020-04-30
NCT04146948 The Differences of Muscle Activity Between Patients With COPD and Healthy Adults https://ClinicalTrials.gov/show/NCT04146948 Recruiting National Cheng-Kung University Hospital 2021-12-31
NCT04142957 COPD Pal Phase 1: A Self-management App in COPD https://ClinicalTrials.gov/show/NCT04142957 Recruiting Hywel Dda Health Board 2019-11-30
NCT04140097 Predictors of Acute Exacerbation in Patients With COPD - an Observational Study https://ClinicalTrials.gov/show/NCT04140097 Recruiting Schön Klinik Berchtesgadener Land 2023-02-25
NCT04105088 Bayis Ilh Tus - A Strong Breath: Prevalence and Contributors to COPD in First Nations Communities in British Columbia https://ClinicalTrials.gov/show/NCT04105088 Recruiting University of British Columbia 2023-03-31
NCT04097223 A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT04097223 Completed Boehringer Ingelheim 2020-06-05
NCT04101448 Prevalence of Bronchiectasis in COPD Patients https://ClinicalTrials.gov/show/NCT04101448 Recruiting Assiut University 2020-09-01
NCT04081740 Biological Determinants of Sputum Rheology in Chronic Airway Diseases https://ClinicalTrials.gov/show/NCT04081740 Completed University Hospital, Montpellier 2019-10-15
NCT04074499 The Risk of Falling in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04074499 Completed Istanbul University-Cerrahpasa 2019-10-22
NCT04048954 Use of a Smartphone Application on the Detection of Complications Related to Smoking https://ClinicalTrials.gov/show/NCT04048954 Completed Weprom 2020-06-01
NCT04045418 A Study on the Microcirculatory Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With COPD https://ClinicalTrials.gov/show/NCT04045418 Recruiting Zhejiang Chinese Medical University 2020-12-31
NCT04046640 A Study on the Heat Transport Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris https://ClinicalTrials.gov/show/NCT04046640 Recruiting Zhejiang Chinese Medical University 2020-12-31
NCT04024735 Mechanisms of COPD Exacerbation Recurrence https://ClinicalTrials.gov/show/NCT04024735 Recruiting University College, London 2022-02-01
NCT04023409 The Identification of Phenotypes in Patients With Severe Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04023409 Completed University Medical Center Groningen 2019-07-10
NCT04011475 A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment https://ClinicalTrials.gov/show/NCT04011475 Active, not recruiting Boehringer Ingelheim 2020-06-30
NCT04011735 Re-usable Respimat® Soft MistTM Inhaler Study https://ClinicalTrials.gov/show/NCT04011735 Completed Boehringer Ingelheim 2020-02-13
NCT04008017 Eosinophilic Cationic Protein as a Biomarker in Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04008017 Recruiting Assiut University 2020-09-30
NCT04006015 Activity, Balance and COPD (ABCOPD) https://ClinicalTrials.gov/show/NCT04006015 Recruiting Imperial College London 2021-10-31
NCT04008615 Comparison of the Cardiopulmonary and Gaz-exchange Response Between the Six-minute Stepper Test and the Incremental Cardiopulmonary Exercise Testing in Patients With Chronicle Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04008615 Recruiting ADIR Association 2022-06-30
NCT04004689 6-minute Stepper Test and Pulmonary Rehabilitation in Patients With Severe to Very Severe Chronicle Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT04004689 Recruiting ADIR Association 2022-06-30
NCT03987633 EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality https://ClinicalTrials.gov/show/NCT03987633 Recruiting Future Genetics Limited 2024-02-05
NCT03979807 A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT03979807 Completed Boehringer Ingelheim 2019-06-11
NCT03950531 The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD https://ClinicalTrials.gov/show/NCT03950531 Completed Ministry of Health, Turkey 2014-12-25
NCT03945968 The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. https://ClinicalTrials.gov/show/NCT03945968 Recruiting Russian Federation of Anesthesiologists and Reanimatologists 2020-12-30
NCT03934749 Non-invasive Home Ventilation in Patients With Severe Hypercapnic Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03934749 Recruiting Centre Hospitalier Universitaire de Besancon 2020-06-30
NCT03893409 GIRH Chronic Obstructive Pulmonary Disease Observational Study https://ClinicalTrials.gov/show/NCT03893409 Recruiting The First Affiliated Hospital of Guangzhou Medical University 2020-12-30
NCT03889964 Exercise Capacity in COPD https://ClinicalTrials.gov/show/NCT03889964 Recruiting Heinrich-Heine University, Duesseldorf 2020-12-31
NCT03858348 A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination https://ClinicalTrials.gov/show/NCT03858348 Recruiting Elpen Pharmaceutical Co. Inc. 2019-12-31
NCT03857061 A Wearable and a Self-management Application for Chronic Obstructive Pulmonary Disease (COPD) Patients at Home https://ClinicalTrials.gov/show/NCT03857061 Recruiting University Health Network, Toronto 2020-12-30
NCT03845257 Correlation of FeNO, Blood Eosinophils, Bronchoalveolar Lavage Findings and Bronchial Epithelium Histopathology in Patients With Chronic Obstructive Pulmonary Disease and Asthma https://ClinicalTrials.gov/show/NCT03845257 Recruiting Heidelberg University 2020-08-31
NCT03804138 Immune Damage and Vaccination in COPD Patients https://ClinicalTrials.gov/show/NCT03804138 Recruiting Centre Hospitalier Intercommunal Creteil 2019-03-20
NCT03754881 Efficacy of 8-week Supervision in Home Based Pulmonary Rehabilitation https://ClinicalTrials.gov/show/NCT03754881 Recruiting Asan Medical Center 2019-08-31
NCT03755544 Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD https://ClinicalTrials.gov/show/NCT03755544 Completed Orion Corporation, Orion Pharma 2020-02-13
NCT03745547 An Exploratory, Observational, Non-interventional, Open Label, Remote Pilot Study to Assess Adherence in COPD Subjects https://ClinicalTrials.gov/show/NCT03745547 Active, not recruiting Spire, Inc. 2020-04-15
NCT03709498 Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03709498 Recruiting Evangelismos Hospital 2020-06-30
NCT03692117 Extracorporeal Carbon Dioxide Removal in Severe Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT03692117 Recruiting China-Japan Friendship Hospital 2020-12-31
NCT03663569 A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler https://ClinicalTrials.gov/show/NCT03663569 Completed Boehringer Ingelheim 2019-10-04
NCT03657121 Mortality and Symptom Burden Post Hospitalisation With COPD https://ClinicalTrials.gov/show/NCT03657121 Active, not recruiting Northumbria Healthcare NHS Foundation Trust 2020-08-31
NCT03660501 Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease - an Observational Study https://ClinicalTrials.gov/show/NCT03660501 Active, not recruiting University Hospital Bispebjerg and Frederiksberg 2019-12-21
NCT03653611 The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2) https://ClinicalTrials.gov/show/NCT03653611 Active, not recruiting Weill Medical College of Cornell University 2020-04-30
NCT03633838 Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China https://ClinicalTrials.gov/show/NCT03633838 Completed AstraZeneca 2017-02-28
NCT03627858 Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting https://ClinicalTrials.gov/show/NCT03627858 Active, not recruiting Chiesi SA/NV 2020-06-30
NCT03615365 COPD Breathing Record Study 2 https://ClinicalTrials.gov/show/NCT03615365 Completed Cambridge Respiratory Innovations Limited 2018-10-18
NCT03604146 Quality Control for Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03604146 Active, not recruiting Guangzhou Institute of Respiratory Disease 2019-08-31
NCT03611777 The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids. https://ClinicalTrials.gov/show/NCT03611777 Completed Boehringer Ingelheim 2020-01-31
NCT03591978 Isolation of Circulating Pulmonary Cells in COPD and Its Relationship With Clinical Relevant Outcomes (IbICEnCa) https://ClinicalTrials.gov/show/NCT03591978 Recruiting Universidad de Granada 2020-11-01
NCT03591562 Imaging Progression of Chronic Obstructive Pulmonary Disease Using MRI and CT (MR-COPDII) https://ClinicalTrials.gov/show/NCT03591562 Enrolling by invitation University Hospital Heidelberg 2020-09-30
NCT03581227 The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1) https://ClinicalTrials.gov/show/NCT03581227 Recruiting Weill Medical College of Cornell University 2020-12-01
NCT03548857 Muscle Function After Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT03548857 Recruiting Rigshospitalet, Denmark 2020-04-30
NCT03543176 Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness https://ClinicalTrials.gov/show/NCT03543176 Completed GlaxoSmithKline 2019-08-21
NCT03522376 Inspiratory Muscle Activation Patterns in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03522376 Completed National Taiwan University Hospital 2018-12-20
NCT03480347 The BLF Early COPD Development Partnership Grant https://ClinicalTrials.gov/show/NCT03480347 Recruiting Imperial College London 2020-09-03
NCT03474484 Calprotectin I Serum as a Diagnostic Marker https://ClinicalTrials.gov/show/NCT03474484 Completed St. Olavs Hospital 2018-09-14
NCT04456205 Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT04456205 Recruiting National Taiwan University Hospital 2021-10-31
NCT03473119 Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia https://ClinicalTrials.gov/show/NCT03473119 Recruiting Taipei Medical University WanFang Hospital 2021-03-19
NCT03467815 Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03467815 Completed Bispebjerg Hospital 2018-06-07
NCT03465332 Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions https://ClinicalTrials.gov/show/NCT03465332 Completed GlaxoSmithKline 2018-08-30
NCT03450603 Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03450603 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2020-12-30
NCT03436511 Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT03436511 Completed GlaxoSmithKline 2018-10-31
NCT03419962 Greek NIS Spiolto ELLACTO https://ClinicalTrials.gov/show/NCT03419962 Completed Boehringer Ingelheim 2018-11-09
NCT03425760 A Cross-sectional Study of COPD and Symptom Variability in MEA Countries https://ClinicalTrials.gov/show/NCT03425760 Completed AstraZeneca 2017-03-31
NCT01263340 Characterisation of People With COPD https://ClinicalTrials.gov/show/NCT01263340 Completed National Services for Health Improvement Ltd 2013-04-30
NCT01254032 Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD https://ClinicalTrials.gov/show/NCT01254032 Completed GlaxoSmithKline 2011-11-30
NCT01248507 Predictive Questionnaires for Risk of Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbations https://ClinicalTrials.gov/show/NCT01248507 Completed AstraZeneca 2013-04-30
NCT01245933 Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD https://ClinicalTrials.gov/show/NCT01245933 Active, not recruiting Philipps University Marburg Medical Center 2013-12-31
NCT01219946 A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01219946 Completed AstraZeneca 2011-03-31
NCT01216592 Airway Inflammation, Symptoms and Lung Function in COPD https://ClinicalTrials.gov/show/NCT01216592 Completed Università degli Studi di Ferrara 2011-01-31
NCT01215825 The Doses of Systemic Steroid in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) https://ClinicalTrials.gov/show/NCT01215825 Completed Far Eastern Memorial Hospital 2010-07-31
NCT01204970 Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients https://ClinicalTrials.gov/show/NCT01204970 Completed KU Leuven 2016-07-31
NCT01195064 Endothelial Function Study Before Cardiovascular Surgery https://ClinicalTrials.gov/show/NCT01195064 Active, not recruiting University Hospital, Grenoble 2020-07-31
NCT01179178 A Dangerous Triad in Ageing and in Chronic Obstructive Pulmonary Disease (COPD) - Reduced Muscle Mass, Impaired Muscle Function and Malnutrition https://ClinicalTrials.gov/show/NCT01179178 Completed Göteborg University 2009-12-31
NCT01169727 Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand https://ClinicalTrials.gov/show/NCT01169727 Completed AstraZeneca 2012-03-31
NCT01156701 Prophylactic Efficacy of Relenza Against Influenza A and B https://ClinicalTrials.gov/show/NCT01156701 Completed GlaxoSmithKline 2010-05-31
NCT03871933 Autonomic Function in COPD and Risk for Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03871933 Completed Heinrich-Heine University, Duesseldorf 2019-08-31
NCT01146392 An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01146392 Completed AstraZeneca 2011-09-30
NCT01145300 Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01145300 Completed Leiden University Medical Center 2011-05-31
NCT01141452 Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD https://ClinicalTrials.gov/show/NCT01141452 Completed Research in Real-Life Ltd 2007-06-30
NCT01145053 Drug Use Survey of RESPIMAT in Patients With COPD https://ClinicalTrials.gov/show/NCT01145053 Completed Boehringer Ingelheim 2011-12-31
NCT01125098 Comparison of a Serum PRO-CT Guided Treatment and the Recommended Antibiotic Treatment for COPD https://ClinicalTrials.gov/show/NCT01125098 Completed University of Modena and Reggio Emilia 2011-07-31
NCT01114386 Clinical Assessment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and/or Chronic Heart Failure (CHF) https://ClinicalTrials.gov/show/NCT01114386 Completed University of Modena and Reggio Emilia 2011-07-31
NCT01110564 Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease https://ClinicalTrials.gov/show/NCT01110564 Completed AstraZeneca 2010-12-31
NCT01099410 Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM) https://ClinicalTrials.gov/show/NCT01099410 Completed VA Office of Research and Development 2015-06-30
NCT01096303 Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT01096303 Completed The University of Texas Health Science Center, Houston 2016-12-31
NCT01096173 Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) Sputum https://ClinicalTrials.gov/show/NCT01096173 Completed Pulmatrix Inc. 2010-06-30
NCT01067248 Chronic Obstructive Pulmonary Disease (COPD) and Osteoporosis https://ClinicalTrials.gov/show/NCT01067248 Completed Catharina Ziekenhuis Eindhoven 2012-12-31
NCT01036763 Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example https://ClinicalTrials.gov/show/NCT01036763 Completed Boehringer Ingelheim 2010-08-31
NCT01033669 Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction https://ClinicalTrials.gov/show/NCT01033669 Completed Pfizer 2010-02-28
NCT01033266 Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome https://ClinicalTrials.gov/show/NCT01033266 Completed University of Oklahoma 2014-02-28
NCT01019538 Pre-flight Titration of Supplemental Oxygen https://ClinicalTrials.gov/show/NCT01019538 Completed Oslo University Hospital 2010-04-30
NCT01016587 Symptom Clusters and Immune Markers in Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Longitudinal Study https://ClinicalTrials.gov/show/NCT01016587 Completed Oslo University Hospital 2013-10-31
NCT01013948 Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting https://ClinicalTrials.gov/show/NCT01013948 Completed GlaxoSmithKline 2009-05-31
NCT01013922 A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting https://ClinicalTrials.gov/show/NCT01013922 Completed AstraZeneca 2010-03-31
NCT01007734 Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT01007734 Completed AstraZeneca 2010-07-31
NCT01006135 Spiriva Observational Study Measuring Saint George’s Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region https://ClinicalTrials.gov/show/NCT01006135 Completed Boehringer Ingelheim 2011-06-30
NCT01006200 Factors to Obstructive Granulation Tissue Formation After Ultraflex Stenting in Benign Tracheal Narrowing https://ClinicalTrials.gov/show/NCT01006200 Completed Chang Gung Memorial Hospital 2007-09-30
NCT00992498 Rehabilitation in Chronic Obstructive Pulmonary Disease Outpatients https://ClinicalTrials.gov/show/NCT00992498 Completed Villa Pineta Hospital 2008-12-31
NCT00974064 The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease https://ClinicalTrials.gov/show/NCT00974064 Active, not recruiting Weill Medical College of Cornell University 2020-03-31
NCT00920348 The Canadian Cohort Obstructive Lung Disease https://ClinicalTrials.gov/show/NCT00920348 Active, not recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2022-12-31
NCT00903955 Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease https://ClinicalTrials.gov/show/NCT00903955 Completed University of North Carolina, Chapel Hill 2012-03-31
NCT00896584 Exercise Pulseoximetry for Pre-flight Evaluation of Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT00896584 Completed LHL Helse 2010-11-30
NCT00898859 Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial Dysfunction https://ClinicalTrials.gov/show/NCT00898859 Completed University Medical Center Groningen 2012-05-31
NCT00894426 Patient’s Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease https://ClinicalTrials.gov/show/NCT00894426 Completed AstraZeneca NA
NCT00890136 Chronic Obstructive Pulmonary Disease (COPD) and Domestic Endotoxin (CODE) https://ClinicalTrials.gov/show/NCT00890136 Completed Johns Hopkins University 2014-03-31
NCT00889447 Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00889447 Completed Johns Hopkins University 2017-05-31
NCT00883701 Granzymes and Perforin at the Onset of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations https://ClinicalTrials.gov/show/NCT00883701 Completed University of Thessaly 2008-08-31
NCT00871637 Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction https://ClinicalTrials.gov/show/NCT00871637 Completed University of Nebraska 2009-06-30
NCT00870857 Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center https://ClinicalTrials.gov/show/NCT00870857 Completed University of Pittsburgh 2013-10-31
NCT00870246 Diaphragmatic Mobility and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00870246 Completed University of Sao Paulo 2008-05-31
NCT00869544 Pneumocystis in Pathogenesis of HIV-associated Emphysema https://ClinicalTrials.gov/show/NCT00869544 Completed University of Pittsburgh 2010-09-30
NCT03443505 NRD to Predict COPD Exacerbations at Home https://ClinicalTrials.gov/show/NCT03443505 Completed Guy’s and St Thomas’ NHS Foundation Trust 2019-06-06
NCT01750658 Study of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations In Spain https://ClinicalTrials.gov/show/NCT01750658 Completed Cimera 2009-12-31
NCT00837629 Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00837629 Completed AstraZeneca 2007-09-30
NCT00831220 Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00831220 Completed Hospital Universitari Son Dureta 2007-10-31
NCT03724877 Effectiveness of Triple Therapy in COPD https://ClinicalTrials.gov/show/NCT03724877 Completed Boehringer Ingelheim 2018-11-12
NCT03131362 Realize the Current Situation of COPD Patients in China https://ClinicalTrials.gov/show/NCT03131362 Active, not recruiting AstraZeneca 2020-05-31
NCT03264924 Improving Physical Activity in Rehabilitation https://ClinicalTrials.gov/show/NCT03264924 Completed Liverpool Heart and Chest Hospital NHS Foundation Trust 2020-01-30
NCT01388166 ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice https://ClinicalTrials.gov/show/NCT01388166 Completed Boehringer Ingelheim 2013-12-31
NCT01460264 An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study https://ClinicalTrials.gov/show/NCT01460264 Enrolling by invitation Region Skane 2020-12-31
NCT04172701 A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD) https://ClinicalTrials.gov/show/NCT04172701 Active, not recruiting Boehringer Ingelheim 2020-06-30
NCT03591263 Clinical Outcomes in Patients Referred to Pulmonary Rehabilitation https://ClinicalTrials.gov/show/NCT03591263 Recruiting National Taiwan University Hospital 2022-06-25
NCT02750189 The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea https://ClinicalTrials.gov/show/NCT02750189 Completed Konkuk University Medical Center 2017-01-31
NCT02725294 Understanding Patient Management of COPD Exacerbations https://ClinicalTrials.gov/show/NCT02725294 Active, not recruiting VA Puget Sound Health Care System 2019-11-30
NCT03954132 Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®) https://ClinicalTrials.gov/show/NCT03954132 Recruiting Boehringer Ingelheim 2021-04-01
NCT02157844 Fat Metabolism in OSA and COPD https://ClinicalTrials.gov/show/NCT02157844 Active, not recruiting Texas A&M University 2017-12-31
NCT02051166 Clinical Practice of AECOPD Management in China https://ClinicalTrials.gov/show/NCT02051166 Completed AstraZeneca 2014-08-31
NCT01768754 Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01768754 Completed West Park Healthcare Centre 2013-02-28
NCT04326309 Audio Data Collection for Identification and Classification of Coughing https://ClinicalTrials.gov/show/NCT04326309 Recruiting HealthMode Inc. 2022-09-25
NCT03957759 Early Signs of Altitude Illness in Patients With COPD https://ClinicalTrials.gov/show/NCT03957759 Recruiting University of Zurich 2020-09-30
NCT00791518 Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy https://ClinicalTrials.gov/show/NCT00791518 Completed GlaxoSmithKline 2009-05-31
NCT00787748 COPD and Cardiovascular Risk in the Population https://ClinicalTrials.gov/show/NCT00787748 Completed Cimera 2008-06-30
NCT00784342 Validation of PROMIS Banks With COPD Exacerbations https://ClinicalTrials.gov/show/NCT00784342 Completed University of North Carolina, Chapel Hill 2009-06-30
NCT00783991 Investigating the Impact of Mode of Administration on Item Response https://ClinicalTrials.gov/show/NCT00783991 Completed Stony Brook University 2009-12-31
NCT00774176 Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations https://ClinicalTrials.gov/show/NCT00774176 Completed Temple University 2008-05-31
NCT00772733 A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment https://ClinicalTrials.gov/show/NCT00772733 Completed AstraZeneca 2010-12-31
NCT00757120 Biomarkers and Genetic Factors Related to Emphysema https://ClinicalTrials.gov/show/NCT00757120 Completed Washington University School of Medicine 2011-09-30
NCT00756522 Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation https://ClinicalTrials.gov/show/NCT00756522 Completed Washington University School of Medicine 2016-05-31
NCT00740337 Factors That Affect the Development of COPD Symptoms https://ClinicalTrials.gov/show/NCT00740337 Completed Washington University School of Medicine 2016-02-29
NCT00740220 Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation https://ClinicalTrials.gov/show/NCT00740220 Completed Wake Forest University Health Sciences 2009-01-31
NCT00734266 Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00734266 Completed Massachusetts General Hospital 2010-12-31
NCT00725673 Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients. https://ClinicalTrials.gov/show/NCT00725673 Completed Catharina Ziekenhuis Eindhoven 2009-04-30
NCT00725309 Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00725309 Completed Washington University School of Medicine 2017-12-31
NCT00722267 European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT00722267 Completed AstraZeneca NA
NCT00710463 Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation https://ClinicalTrials.gov/show/NCT00710463 Completed Deutsche Lungenstiftung e.V. 2007-09-30
NCT00699699 Observational Non-Interventional Study With Spiriva Respimat in COPD Patients https://ClinicalTrials.gov/show/NCT00699699 Completed Boehringer Ingelheim 2009-01-31
NCT00697177 The Prevalence of Gastro-oesophageal Reflux in Chronic Lung Disease https://ClinicalTrials.gov/show/NCT00697177 Completed Bayside Health 2009-06-30
NCT00675454 Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema https://ClinicalTrials.gov/show/NCT00675454 Enrolling by invitation Washington University School of Medicine 2020-12-31
NCT00662805 Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00662805 Completed GlaxoSmithKline 2008-09-30
NCT00660738 Functional Tests in Individuals With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00660738 Completed Universidade Federal de Sao Carlos 2008-02-29
NCT00655954 Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) Sputum https://ClinicalTrials.gov/show/NCT00655954 Completed Imperial College London 2010-03-31
NCT00638183 Special Survey Long-term Treatment With Tiotropium on COPD https://ClinicalTrials.gov/show/NCT00638183 Completed Boehringer Ingelheim 2009-01-31
NCT00624377 Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice https://ClinicalTrials.gov/show/NCT00624377 Completed Boehringer Ingelheim 2010-03-31
NCT00621582 Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities https://ClinicalTrials.gov/show/NCT00621582 Completed Boehringer Ingelheim 2008-02-29
NCT00620516 Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients https://ClinicalTrials.gov/show/NCT00620516 Completed Boehringer Ingelheim 2007-12-31
NCT00615992 Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines https://ClinicalTrials.gov/show/NCT00615992 Completed Boehringer Ingelheim 2008-04-30
NCT00618137 Inert Dusts and Pathology of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00618137 Completed Medical University of Vienna 2011-12-31
NCT00611520 Symbicort in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00611520 Completed AstraZeneca 2005-12-31
NCT00612976 Symbicort in Chronic Obstruktive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00612976 Completed AstraZeneca 2006-09-30
NCT00608764 Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00608764 Active, not recruiting Brigham and Women’s Hospital 2022-12-31
NCT00595114 Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00595114 Completed Brigham and Women’s Hospital 2009-08-31
NCT00549445 Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00549445 Completed University of Alabama at Birmingham 2011-07-31
NCT00542282 Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma https://ClinicalTrials.gov/show/NCT00542282 Completed Deep Breeze NA
NCT00540163 Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea https://ClinicalTrials.gov/show/NCT00540163 Completed Boehringer Ingelheim 2007-11-30
NCT00511290 Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung https://ClinicalTrials.gov/show/NCT00511290 Completed Tel-Aviv Sourasky Medical Center NA
NCT00504738 Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease https://ClinicalTrials.gov/show/NCT00504738 Completed Weill Medical College of Cornell University NA
NCT00477074 Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPD https://ClinicalTrials.gov/show/NCT00477074 Completed Hospital Universitari Son Dureta NA
NCT00457301 Using Health-related Quality of Life (HRQL) in Routine Clinical Care https://ClinicalTrials.gov/show/NCT00457301 Completed University of Alberta 2007-04-30
NCT00452764 Regulatory T Cells in COPD https://ClinicalTrials.gov/show/NCT00452764 Completed Groningen Research Institute for Asthma and COPD NA
NCT00448604 Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations https://ClinicalTrials.gov/show/NCT00448604 Completed University Hospital, Geneva 2009-09-30
NCT00448500 Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00448500 Completed Chinese University of Hong Kong 2008-01-31
NCT00442468 Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath https://ClinicalTrials.gov/show/NCT00442468 Completed GlaxoSmithKline 2007-09-30
NCT00441389 Infectious Etiology of Acute Exacerbations of COPD https://ClinicalTrials.gov/show/NCT00441389 Completed Chinese University of Hong Kong NA
NCT00404430 Protocol Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00404430 Active, not recruiting University Hospital, Grenoble 2021-02-28
NCT00394940 Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00394940 Completed University of Arizona 2013-01-31
NCT00380796 A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). https://ClinicalTrials.gov/show/NCT00380796 Completed Centocor, Inc. 2009-12-31
NCT00319813 General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment https://ClinicalTrials.gov/show/NCT00319813 Completed Boehringer Ingelheim NA
NCT00298389 Macrophage Phagocytosis in COPD https://ClinicalTrials.gov/show/NCT00298389 Completed Imperial College London 2010-12-31
NCT00292552 Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints https://ClinicalTrials.gov/show/NCT00292552 Completed GlaxoSmithKline 2010-02-28
NCT00281242 Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00281242 Completed University of Michigan 2010-06-30
NCT00281229 T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00281229 Completed University of Michigan 2014-09-30
NCT00281216 Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations https://ClinicalTrials.gov/show/NCT00281216 Completed University of Michigan 2010-09-30
NCT00281203 Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD https://ClinicalTrials.gov/show/NCT00281203 Completed University of Michigan 2010-07-31
NCT00281190 Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function https://ClinicalTrials.gov/show/NCT00281190 Completed University of Michigan 2014-10-31
NCT00268866 Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics https://ClinicalTrials.gov/show/NCT00268866 Completed Boehringer Ingelheim NA
NCT00259909 Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00259909 Completed GlaxoSmithKline 2006-11-07
NCT00147095 Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00147095 Completed Imperial College London 2005-02-28
NCT00106470 Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics https://ClinicalTrials.gov/show/NCT00106470 Completed University of Pittsburgh 2010-01-31
NCT00087906 Disability and Health Outcomes in COPD https://ClinicalTrials.gov/show/NCT00087906 Completed University of California, San Francisco 2009-05-31
NCT00037739 Chronic Obstructive Pulmonary Disease Gene Localization https://ClinicalTrials.gov/show/NCT00037739 Completed University of Utah NA
NCT00605540 Chronic Obstructive Pulmonary Disease Markers and Prognosis https://ClinicalTrials.gov/show/NCT00605540 Completed UPECLIN HC FM Botucatu Unesp 2010-03-31
NCT00018408 Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00018408 Completed VA Office of Research and Development NA
NCT00006513 Assessing the Occupation Burden in COPD https://ClinicalTrials.gov/show/NCT00006513 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00006419 Diet and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00006419 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005720 Lay-Led Smoking Cessation Approach for Southeast Asian Men https://ClinicalTrials.gov/show/NCT00005720 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00006306 Effects of Chronic Ozone Exposure on Lung Function https://ClinicalTrials.gov/show/NCT00006306 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005717 Medication Adherence in COPD–A Self-Regulation Study https://ClinicalTrials.gov/show/NCT00005717 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005537 Genetics of Airway Responsiveness and Lung Function https://ClinicalTrials.gov/show/NCT00005537 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005697 Intervention for Resistant Pregnant Smokers https://ClinicalTrials.gov/show/NCT00005697 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005425 Statistical Analysis of Vlagtwedde-Vlaardingen Data Set https://ClinicalTrials.gov/show/NCT00005425 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005292 Alpha1-antitrypsin Deficiency Registry https://ClinicalTrials.gov/show/NCT00005292 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005382 Sources of Variability in Peak Expiratory Flow https://ClinicalTrials.gov/show/NCT00005382 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005288 Epidemiology and Pulmonary Response To Organic Dust Exposure https://ClinicalTrials.gov/show/NCT00005288 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005370 Longitudinal Study of Cortisol and Pulmonary Function https://ClinicalTrials.gov/show/NCT00005370 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005123 Honolulu Heart Program https://ClinicalTrials.gov/show/NCT00005123 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005285 Effect of Maternal Smoking On Neonatal Lung Function https://ClinicalTrials.gov/show/NCT00005285 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005284 Epidemiology of Airway Responsiveness https://ClinicalTrials.gov/show/NCT00005284 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005282 Prospective Evaluation of Airways Reactivity https://ClinicalTrials.gov/show/NCT00005282 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005281 Early Risk Predictors For Chronic Pulmonary Disease https://ClinicalTrials.gov/show/NCT00005281 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005280 Specialized Center of Research in Occupational and Immunologic Lung Disease https://ClinicalTrials.gov/show/NCT00005280 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005279 Tucson Epidemiology Study of Chronic Obstructive Lung Diseases https://ClinicalTrials.gov/show/NCT00005279 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03755505 The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT03755505 Recruiting Asan Medical Center 2019-03-31
NCT03187236 Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China https://ClinicalTrials.gov/show/NCT03187236 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03185572 Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in China https://ClinicalTrials.gov/show/NCT03185572 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03157817 Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03157817 Completed Loughborough University 2017-08-15
NCT03120481 Controls for Respiratory Diseases https://ClinicalTrials.gov/show/NCT03120481 Recruiting Seoul National University Hospital 2037-02-28
NCT03037255 Association of Long-term Conditions With Survival Following Heart Attack in England and Wales https://ClinicalTrials.gov/show/NCT03037255 Active, not recruiting University of Leeds 2013-12-31
NCT03011853 Survival After Failed First-line Non-invasive Ventilation in Acute on Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03011853 Completed Swedish Intensive Care Registry 2018-12-31
NCT03014609 Cardiovascular Risk and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03014609 Recruiting University Hospital, Grenoble 2020-11-30
NCT02853383 Registry of COPD Patients From Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow https://ClinicalTrials.gov/show/NCT02853383 Recruiting Interregional Public Organization, Russian Respiratory Society 2019-01-31
NCT02811588 Registry of Stable Hypercapnic Chronic Obstructive Pulmonary Disease Treated With Non-Invasive Ventilation https://ClinicalTrials.gov/show/NCT02811588 Completed ResMed 2017-12-31
NCT02803242 COPD Patient-Powered Research Network https://ClinicalTrials.gov/show/NCT02803242 Recruiting COPD Foundation 2025-01-31
NCT02732444 Erythrocytes Membrane Stability in COPD Patients in Long-Term Home Oxygen Therapy https://ClinicalTrials.gov/show/NCT02732444 Completed Federal University of Uberlandia 2017-08-31
NCT02659189 Hospitalary Chronic Obstructive Pulmonary Disease Registry https://ClinicalTrials.gov/show/NCT02659189 Recruiting Hospital Italiano de Buenos Aires 2019-12-31
NCT02552160 DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy https://ClinicalTrials.gov/show/NCT02552160 Completed AstraZeneca 2017-12-31
NCT02527486 Seoul National University Airway Registry https://ClinicalTrials.gov/show/NCT02527486 Recruiting Seoul National University Hospital 2021-12-31
NCT02300090 A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD) https://ClinicalTrials.gov/show/NCT02300090 Completed AstraZeneca 2018-08-23
NCT02119494 Phenotypes of COPD in Central and Eastern Europe https://ClinicalTrials.gov/show/NCT02119494 Completed Masaryk University 2015-12-31
NCT02078622 Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPD https://ClinicalTrials.gov/show/NCT02078622 Completed StratiHealth 2016-03-31
NCT02045394 Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study https://ClinicalTrials.gov/show/NCT02045394 Completed University of Milan 2015-10-31
NCT01794390 Handling Inhalers - Technique Error Comparison (HI-TEC) https://ClinicalTrials.gov/show/NCT01794390 Completed Research in Real-Life Ltd 2014-03-31
NCT01785706 COPD Research Registry https://ClinicalTrials.gov/show/NCT01785706 Completed COPD Foundation 2015-04-30
NCT04285047 Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD) https://ClinicalTrials.gov/show/NCT04285047 Enrolling by invitation Optimum Patient Care 2022-12-31
NCT04263727 A Study of Patients With Chronic Disease https://ClinicalTrials.gov/show/NCT04263727 Recruiting Target PharmaSolutions, Inc. 2035-02-28
NCT04263961 An Integrative Genomic Approach to Solve tHe Puzzle of sevERe earLy-Onset COPD https://ClinicalTrials.gov/show/NCT04263961 Recruiting University Medical Center Groningen 2022-03-31
NCT04259736 Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD https://ClinicalTrials.gov/show/NCT04259736 Recruiting Huashan Hospital 2020-12-31
NCT04206098 Chart Review of Patients With COPD, Using Electronic Medical Records and Artificial Intelligence https://ClinicalTrials.gov/show/NCT04206098 Recruiting Sociedad Española de Neumología y Cirugía Torácica 2020-10-01
NCT04180670 Prevalence of Urinary Incontinence and Evaluation of Related Factors in Patients With COPD https://ClinicalTrials.gov/show/NCT04180670 Recruiting Sanko University 2020-03-31
NCT03942302 Characterization of Variable MARrcha’s Diary Variables as a Useful Measure https://ClinicalTrials.gov/show/NCT03942302 Recruiting Fundacio Catalana de Pneumologia 2019-12-01
NCT03853642 Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03853642 Completed Universitair Ziekenhuis Brussel 2020-03-28
NCT03680495 Steroid Resistance During COPD Exacerbations With Respiratory Failure https://ClinicalTrials.gov/show/NCT03680495 Recruiting University of Colorado, Denver 2020-03-31
NCT03642613 The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD. https://ClinicalTrials.gov/show/NCT03642613 Completed AstraZeneca 2019-03-15
NCT03604952 Effects of Ramadan Observance in Male Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03604952 Completed Faculty of Medicine, Sousse 2015-07-14
NCT03577795 A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory Society https://ClinicalTrials.gov/show/NCT03577795 Active, not recruiting AstraZeneca 2021-03-31
NCT03540862 Negative Pressure Ventilator in Long-term Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT03540862 Recruiting Chang Gung Memorial Hospital 2020-12-30
NCT03437252 Physical Activity in COPD Acute Exacerbation Patients https://ClinicalTrials.gov/show/NCT03437252 Enrolling by invitation Samsung Medical Center 2019-11-19
NCT03432234 Respiratory Microbiome and COPD Exacerbations (RESMECOPD) https://ClinicalTrials.gov/show/NCT03432234 Active, not recruiting Corporacion Parc Tauli 2018-12-31
NCT03182309 Registry for Chronic Obstructive Pulmonary Disease With Sleep Apnea Hypopnea Syndrome in China https://ClinicalTrials.gov/show/NCT03182309 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT02629432 Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT https://ClinicalTrials.gov/show/NCT02629432 Completed University Hospital Heidelberg 2016-07-31
NCT00307281 Emphysema/COPD Research Registry https://ClinicalTrials.gov/show/NCT00307281 Recruiting University of Pittsburgh 2030-07-31